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SUMMARY 
The object of the work described in this 
thesis has been to determine the tissue 
distribution, development, and properties of 
the purine phosphoribosyltransferases (PRTases), 
especially in man but also in some other animals. 
A major part of the work was directed to the 
study of hypoxanthine guanine phosphoribosyl- 
transferase EC 2.4.2.8 (HGPRTase) in man in view 
of its importance in human metabolism as shown 
by pathological abnormalities resulting from 
its deficiency. 
As existing assay methods would tend to give 
falsely low results, an assay method was developed 
for the purine PRTases from tissues, which 
incorporated thymidine triphosphate as a selective 
inhibitor of 5'- nucleotidase EC 3.1.3.5, to prevent 
the hydrolysis of the PRTase reaction products. 
The specific activity of HGPRTase and adenine 
phosphoribosyltransferase EC 2.4.2.7 (APRTase) was 
determined in tissues from foetuses, children and 
adults. In the central nervous system and, 
unexpectedly, in the testis, HGPRTase activity 
increased during childhood to reach adult 
levels which were several times higher than 
those found in the foetus and in other tissues 
in the adult. The activity of HGPRTase in the 
other tissues studied remained constant or 
increased only slightly during development. 
In central nervous system, APRTase activity 
decreased during the period between foetal and 
neonatal life, while liver APRTase activity 
increased during childhood. In the adult, liver 
activity was about three times that found in 
foetal liver. 
Since it was difficult to obtain human tissues 
between the ages of 2 years and 60 years, a study 
was carried out on the developmental changes in 
rat tissue HGPRTase activity. Complex changes 
in activity were detected, being most marked in 
testis, liver, and cerebral cortex. However, some 
evidence was obtained for a rise in testicular 
HGPRTase occurring during sexual maturation. Low 
activities of HGPRTase were detected in the testis, 
liver, and cerebral cortex of rats at 16 months of 
age which, for the P.V.G. strain of rats used, was 
very old age. 
The electrophoretic properties of the 
purine PRTases were investigated using a newly 
developed detection technique and four isoenzyme 
bands were detected for both HGPRTase and APRTase. 
HGPRTase from several human tissues was 
studied by determining the thermal denaturation 
rate constants and the results suggested the 
possible presence of a tissue specific testicular 
HGPRTase. 
Autoradiographic localisation of testicular 
HGPRTase showed that the majority of the activity 
was in the basal layers of the epithelium of the 
seminiferous tubule. 
As hypoxanthine is the major purine released 
by erythrocytes, and the uptake of hypoxanthine into 
erythrocytes is dependent on HGPRTase, the possible 
effect of differing tissue enzyme activities on the 
uptake of purines by tissues from erythrocytes, was 
investigated in the rabbit using prelabelled rabbit 
erythrocytes. The results demonstrated that 
erythrocyte purines were transported to tissues 
and incorporated into cellular nucleic acids. The 
uptake of purines by tissues from the erythrocytes 
did not bear a simple direct relationship to the 
tissue HGPRTase activity. 
In conclusion, the developmental changes 
detected in HGPRTase activity in the central 
nervous system may provide an explanation for 
the delayed onset of the neurological symptoms 
found in children with the Lesch -Nyhan syndrome 
and would appear to be broadly related to the 
development of function of some parts of the 
central nervous system. The unexpectedly high 
HGPRTase activity located in the seminiferous 
tubule of the testis, and the developmental changes 
in activity found to occur in this tissue, suggest 
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SECTION I 
GENERAL INTRODUCTION: PATHWAYS OF 
PURINE NUCLEOTIDE METABOLISM 
1.1 HISTORICAL 
The existence of the purine phosphoribosyl- 
transferases (PRTases) was first demonstrated by 
Buchanan and co- workers (Williams and Buchanan, 
1953; Remy, Remy and Buchanan, 1955; Korn, Remy 
and Buchanan, 1955), who observed the synthesis of 
adenylic acid and inosinic acid from the free bases 
adenine and hypoxanthine. Using pigeon and beef 
liver homogenates, these workers showed that the 
synthesis of AMP and IMP from adenine or hypoxanthine 
TP 
in the presence of ribose -5- phosphate and AFP, was 
direct and not via adenosine or inosine. 
The enzymes catalysing these reactions were 
characterised, and, in view of their apparently 
peripheral role in purine metabolism, were designated as 
'salvage' pathways for the reutilisation of free purine 
bases (Kornberg, 1957). These salvage reactions thus 
conserved the intact purine ring system, synthesised 
at the expense of five ATP requiring steps in the 
de novo biosynthetic pathway. 
The term 'salvage pathway' is perhaps unfortunate 
as it could imply a lack of importance. The full 
significance of the purine phosphoribosyltransferases was 
2. 
not fully realised until the discovery that children 
with the Lesch -Nyhan syndrome had a congenital 
deficiency of hypoxanthine guanine phosphoribosyl- 
transferase (HGPRTase); these children suffered 
from a massive hyperuricaemia causing atypical gout, 
along with bizarre neurological symptoms. Massive 
increases in de novo purine biosynthesis were later 
demonstrated (Rosenbloom, 1968). 
1.2 THE LESCH -NYHAN SYNDROME 
In 1964, Michael Lesch and William Nyhan reported, 
in a paper entitled "A Familial Disorder of Uric Acid 
Metabolism and Central Nervous System Function" 
(Lesch and Nyhan, 1964), the clinical features of the 
disorder to be known as the Lesch -Nyhan syndrome. 
Children with this disorder showed developmental 
retardation, cerebral palsy, choreoathetosis, and 
hyperuricaemia. The behavioral features of these 
children included physical and verbal aggression, and 
compulsive self -mutilation. The self -mutilation was 
extreme and involved partial amputation of the finger 
and the complete removal of the tissue of the upper 
lips (Fig. 1). These children had to be restrained by 
the use of large padded gloves on the hands, and the 
removal of the teeth. 
Few, if any, of the behavioral symptoms were present 
Fig. 1 
The mutilated upper lip and 
ear tophi in a child with 
the Lesch -Nyhan syndrome (age 
14 years). From W.L. Nyhan 
(1968) Fed. Proc. 27, 1030 
3. 
at birth, and during the first year the children 
appeared to develop and grow normally. Before the 
age of two, however, the neurological and 
behavioral symptoms usually began to develop. 
Dizmang and Cheatham (1970), have made a psychiatric 
study of some of these children, and found they had 
a compulsion to inflict pain; early coincidental 
pain often triggered the compulsion and determined 
the site of self -mutilation. 
It would appear that HGPRTase plays an important 
role in the central nervous system, and a detailed 
study of the distribution and developmental changes 
of HGPRTase activity in the central nervous system may 
enable a fuller understanding of the biochemical 
pathology of this disorder. 
Biochemical studies on children with the Lesch- 
Nyhan syndrome revealed serum uric acid levels of 
10 mg /100 ml (Lesch and Nyhan, 1964) compared to values 
for normal children of 4.0 mg /100 ml (Harkness and 
Nicol, 1969). Urinary uric acid excretion in these 
children was of the order of 50 mg/kg /day, compared to 
values of 10.3 mg/kg /day for normal children (Lesch and 
Nyhan, 1964). Due to the presence of high levels of 
serum uric acid, these children also showed the clinical 
features of gout. Although arthritic processes take 
4. 
several years of hyperuricaemia to develop, three 
of the children examined by Lesch and Nyhan (1964) 
had episodes of acute arthritis. In one of the 
children, an anti- inflammatory response was obtained 
on treatment with colchicine. Many Lesch -Nyhan 
patients presented with haematuria, uric acid 
crystalluria,and with colic and abdominal pain. On 
examination these children were found to have multiple 
tophi in the ears. 
Some aspects of uric acid metabolism in children 
with this syndrome were studied by the administration 
of isotopically labelled glycine. This amino acid was 
chosen for this study as it is incorporated intact into 
the 4,5, and 7 positions of the purine ring system. 
Children with the Lesch -Nyhan syndrome converted 2.25% 
of the glycine into urinary urate compared to 0.12% 
incorporation in control children. This represented 
an increase in de novo purine biosynthesis by a factor 
of twenty (Lesch and Nyhan, 1964). Studies on the 
concentrations of total oxypurines (xanthine + hypoxanthine) 
in the cerebrospinal fluid (C.S.F.) of Lesch -Nyhan 
patients showed that oxypurine concentrations were 
about five times those of control children. The C.S.F. 
xanthine concentrations were similar in control and 
Lesch -Nyhan children, the increase in total oxypurines 
5. 
being due to increased hypoxanthine concentrations 
(Rosenbloom et al., 1970a) 
The line of transmission of the syndrome was 
found to be through the female to the male and was 
shown to be an X linked recessive trait (Nyhan et al., 
1967) . 
The enzymological basis of the Lesch -Nyhan syndrome 
was discovered in 1967 when Seegmiller, Rosenbloom and 
Kelley (1967) showed that tissue extracts from Lesch- 
Nyhan patients were almost completely lacking in 
hypoxanthine guanine phosphoribosyltransferase activity. 
The enzyme defect has subsequently been demonstrated in 
skin fibroblasts (Rosenbloom et al., 1968) and brain 
and liver obtained at necropsy (Rosenbloom et al., 1967). 
Sorensen (1970) has reported residual activities 
of 0.05 - 0.64% of normal in erythrocyte lysates from 
one patient. 
Partial deficiencies of HGPRTase activity of 
0.01 - 17.0% of normal have been reported for erythrocyte 
lysates from members of families with hyperuricaemia 
and gout by Kelley et al. (1967) and Kelley et al. (1969). 
The erythrocyte HGPRTase from these patients with 
partial HGPRTase deficiencies has been shown to be 
more thermolabile than normal in two families, and more 
thermostable in one family (Kelley et al., 1969). 
6. 
A recent and very elegant study by Rubin et al. 
(1971) has demonstrated that the genetic defect in the 
Lesch -Nyhan syndrome results in the production of 
normal amounts of immunologically identifiable but 
catalytically incompetent HGPRTase protein. Similar 
results were obtained in a study of fourteen Lesch -Nyhan 
patients° erythrocyte HGPRTase by Arnold, Meade and 
Kelley (1972). 
Thus, evidence is emerging that the deficiency 
in the Lesch -Nyhan syndrome is probably the result of 
a point mutation in a structural gene, and not the 
result of a deletion of the structural gene or a defect 
in a regulatory gene. 
As many of the symptoms of the Lesch -Nyhan syndrome 
are also found in other diseases of childhood (see 
section 3.2) the only definitive method of diagnosis 
is the demonstration of lack of HGPRTase activity in 
erythrocyte lysates. 
Abnormal Adenine Phosphoribosyltransferase Activity 
Increased erythrocyte adenine phosphoribosyl- 
transferase (APRTase) activity has been reported in 
patients with HGPRTase deficiency by Kelley et al. (1969) 
and Greene, Boyle and Seegmiller (1970) have suggested 
that this is due to stabilisation of the APRTase protein 
by 5- phosphoribosyl -l- pyrophosphate. 
7. 
Increases of up to twice normal erythrocyte 
APRTase activity have been reported (Seegmiller et al., 
1967), and decreases to 20% of normal have been 
reported in four healthy individuals (Henderson et al., 1968b) 
Differences in the heat stability of erythrocyte 
APRTase have been reported, and about 15% of a 
randomly selected population were found to possess 
alleles which were expressed as an unusually heat 
resistant APRTase (Henderson et al., 1968a). 
The kinetic constants for both substrates for 
APRTase from individuals with high or low heat 
stabilities were investigated by Henderson et al. (1968b) 
and abnormal Michealis constants were found for these 
mutant APRTases. 
The inheritance of the APRTase gene is thought to 
be autosomal. 
1.3 HYPDXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 
EC 2.4.2.8 
HGPRTase catalyses the direct reaction of the 
purine bases hypoxanthine, guanine and to a lesser 
extent, xanthine, with 5- phosphoribosyl -l- pyrophosphate 
(PRPP), to form the corresponding 5- mononucleotide and 
pyrophosphate. The enzyme is widely distributed in 
living organisms. HGPRTase has been found in all 
tissues in man which have been examined (Rosenbloom et al., 
8. 
1967; section 3.4) with the exception of 
spermatozoa. It has been detected in brewers' 
yeast (Miller and Bieber, 1968), rats, rabbits, 
(section 3.5; section 3.7), mice (Murray, 1966), 
monkey tissues (Krenitsky, 1969), and S. typhimurium 
(Adye and Gotts, 1966) . In bacteria, there is 
evidence for separate enzymes for hypoxanthine, guanine, 
and xanthine (Kalle and Gotts, 1961). 
Evidence that a single protein is involved for 
the human enzyme is provided by the same rate of loss 
of activity towards both hypoxanthine and guanine 
during heat denaturation (Kelley et al., 1967b). 
Henderson et al. (1968c) has obtained kinetic evidence 
that a single enzyme from human erythrocytes reacts 
with both hypoxanthine and guanine. In addition, loss 
of activity with regard to both substrates is found 
in the Lesch -Nyhan syndrome. 
Erythrocyte HGPRTase has been purified to 
homogeneity by Arnold and Kelley (1971), and shown to 
have a Stokes radius of 36Á with a molecular weight of 
68,000. Arnold and Kelley (1971) concluded that 
HGPRTase was composed of two subunits with the same 
molecular weight and net charge. Interaction between 
the subunits has been suggested by Bakay et al. (1972) 
to be a possible mechanism affecting the total catalytic 
9. 
activity of the enzyme complex. 
A pH optimum of 7.2 - 7.8 has been reported 
for HGPRTase and the enzyme requires divalent cations 
for optimal activity. Maximal activity is obtained 
at 5 mM magnesium concentrations, while increasing 
concentrations of magnesium are inhibitory 
(Krenitsky, Papaioannou and Elion, 1969). The 
inhibition observed at high magnesium concentration 
is compatible with the true substrate being mono - 
magnesium -PRPP, while the di- magnesium -PRPP complex 
is inactive (Gadd and Henderson, 1970a) . HGPRTase 
is strongly inhibited by the sulphydryl group binder 
p- chloromercuribenzoate, implicating an -SH group at 
or near the active site. 
The kinetic constants for erythrocyte HGPRTase 
have been determined by initial velocity and product 
inhibition studies. Apparent Michbalis constants 
for hypoxanthine, guanine, and PRPP for HGPRTase are 
reported by Henderson (1968) to be 10,4, and 200/u.M 
respectively. 
Double reciprocal plots of initial velocity versus 
varying concentrations of the first substrate at a 
series of fixed concentrations of the second substrate, 
yield a series of parallel lines consistent with a 
uni -uni -uni -uni ping pong mechanism (Cleland, 1963). 
10 . 
This is shown in mechanism I, Fig. 2. However, 
product inhibition and IMP -hypoxanthine isotope 
exchange studies suggested an ordered mechanism 
proceding via a ternary complex of the enzyme and 
both substrates (Henderson et al., 1968a), mechanism 
II, Fig. 2. 
These mechanisms have been challenged by 
Krenitsky and Papaioannou (1969) on the grounds that 
the parallel initial velocity plots are unchanged, 
even at substrate concentrations approaching the 
enzyme- substrate dissociation constant. In order 
to reconcile these two mechanisms, Krenitsky and 
Papaioannou (1969) suggested a tentative mechanism 
involving alternate reaction sequences with both binary 
and ternary enzyme -substrate complexes. 
1.4 ADENINE PHOSPHORIBOSYLTRANSFERASE EC 2.4.2.7 
Adenine phosphoribosyltransferase (APRTase) is 
also widely distributed, and has been studied from 
several sources including brewers' yeast (Kornberg, 
Lieberman and Simms, 1955), beef liver (Flaks, Erwin 
and Buchanan, 1957) , and monkey liver (Krenitsky, 1969) . 
APRTase activity has been detected in human 
erythrocytes and several other human tissues studied 
(Rosenbloom et al., 1967; section 3.4). 
A A , c- A E -. EA 
Q B 
1 Jr P 
E'B i====1 E' EQ T_====-2 EAB(EPQ) 
B 
AECHANISMS I II 
Toe abbreviations used are A,B,C,P and Q, 
PP- ribose -P, guanine, iiypoxantnine, 
pyrophosphate and guanylate; E and E', 
free enzyme and enzyme- riuose 5- phosphate 
complex respectively. 
J. biol Chem. 243, 2514. 
Fig. 2 
Suggested possible mechanisms for catalysis 
by HGPRTase 
11. 
The tissue distribution of human APRTase 
activity (section 3.4) differs greatly from that of 
HGPRTase activities, and there would appear to be 
little functional metabolic relationship between the 
two enzymes apart from the similarities in their 
reaction type. 
APRTase from human erythrocytes has been purified 
6730 -fold to a specific activity of 2.5 iumoles /minute /mg 
protein, and was homogeneous as determined by 
polyacrylamide gel electrophoresis and ultracentrifugation 
(Greene, Boyle and Seegmiller, 1969), and was estimated 
to have a molecular weight of 37,000. APRTase from 
human erythrocytes is considerably more heat labile than 
is HGPRTase (Henderson et al., 1969; section 3.2), and 
has a broad pH optimum at about pH 7.0 with Tris /HC1 
buffers (Blair, 1967). 
APRTase from human erythrocytes was, in contrast 
to HGPRTase, found to be resistant to p- chloromercuri- 
benzoate (Greene, Boyle and Seegmiller, 1969). 
The apparent Mich4.lis constants for APRTase from 
the human erythrocyte are reported by Henderson (1968) 
to be 1 and 6 FM respectively for adenine and PRPP. 
An intermediate in de novo purine biosynthesis, 
Az 
5- aminoimidayole,- 4- carboxamide has also been reported 
as a substrate for APRTase, but the apparent Km value is 
12. 
about one thousand times greater than that for 
adenine (Krenitsky et al., 1969) 
The equilibrium for the reaction of APRTase 
favours AMP formation with an equilibrium constant 
of 290 (Hori and Henderson, 1966), but the back 
reaction can be shown to occur by the use of pyro- 
phosphate dependent isotope exchange between AMP and 
adenine. Inhibition of APRTase by both products of 
the reaction has been reported by Hori and Henderson 
(1966) and inhibition by other nucleotide mono and 
triphosphates has been reported. 
The binding requirements for adenine to APRTase 
from Erlich ascites tumour cells have been studied by 
Gadd and Henderson (1970a) and the removal of a proton 
from N -9 was shown to be the rate limiting step for the 
reaction (Gadd and Henderson, 1970b). 
The evidence regarding the reaction mechanism for 
APRTase is contradictory and similar to that for the 
HGPRTase reaction. However, from studies on the 
dependence of AMP- adenine isotope exchange on pyro- 
phosphate the evidence would appear to favour an ordered 
mechanism with the formation of a ternary complex 
(Komberg, Lieberman and Simms, 1955). 
The metabolic role of APRTase remains an enigma, 
as no known enzymic mechanism exists in mammals for the 
13. 
formation of its substrate, adenine (Murray, 1971). 
As small quantities of free adenine are found in 
the urine (Ayvayian and Skaup, 1965), it is possible 
that this arises via the 'back' reaction of APRTase. 
1.5 DE NOVO PURINE BIOSYNTHESIS 
The enzyme involved in the first reaction in 
de novo purine biosynthesis, the formation of 5- phospho- 
ribosyl -1 -amine from PRPP and glutamine (reaction 2, 
Fig. 3), is thought to be the pacemaker enzyme of this 
pathway. This enzyme, phosphoribosylpyrophosphate 
amidotransferase EC 2.4.2.14, has been purified from 
rat liver and exhibits sigmoid kinetics with respect 
to the binding of PRPP ( Wyngaarden and Ashton, 1959). 
This suggests that the enzyme is subject to allosteric 
regulation; the purine nucleotide end -products of the 
pathway, AMP, IMP, and GMP, are strong feedback 
inhibitors of PRPP -amidotransferase and are competitive 
with respect to PRPP (Wyngaarden and Ashton, 1959). 
Detailed studies on the precise nature of the feedback 
inhibition of this enzyme by purine nucleotides are 
however conflicting (Caskey, Ashton and Wyngaarden, 1964), 
and appear to depend on the source of the enzyme and 
the degree of purification obtained. 
The Km for PRPP- amidotransferase with PRPP is 
0.2 - 0.4 mM (Hill and Bennett, 1969; Wyngaarden and 
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Metabolic Pathway leading to the synthesis of inoninie acid. 
Fig. 3 
De Novo purine biosynthetic pathway. From 
Biological Chemistry, Mahler and Cordes p. 824 
14. 
Ashton, 1959), while the normal PRPP concentration 
found in human erythrocytes is 1 - 5 Iu.M and 
concentrations of up to 130 ¡M have been detected 
in cultured fibroblasts (Kelley, Fox and Wyngaarden, 
1970). These intracellular PRPP concentrations are 
considerably lower than the Km for PRPP -amidotransferase. 
The phosphoribosylamine produced in the first 
reaction is metabolised to IMP by nine further enzymic 
reactions, four of which are ATP dependent. 
The IMP produced is converted to AMP and GMP via 
adenylosuccinate and XMP respectively. 
Estimates of de novo purine nucleotide biosynthesis 
in human tissues are unavailable due to the extreme 
lability of the enzymes involved, but studies carried 
out using rat tissues by Howard, Kerson and Appel (1970) 
have shown that the capacity of the liver for de novo 
synthesis exceeds that of brain by a factor of four. 
1.6 INTERCONVERSIONS OF PURINE RIBONUCLEOTIDES AND 
DERIVATIVES 
The interconversions of purine ribonucleotides and 
their derivatives are shown in Fig. 4. 
De novo purine ribonucleotide biosynthesis results 
in the production of IMP, which can be converted to 
AMP and GMP. The formation of AMP or GMP both require 
two separate enzymic steps, one of which is energy 
 m-RNA PRPP GLU -NH2 m-RNA 
I 































Interconversions of purine ribonucleotides. Top to 
bottom; ribonucleotides, ribonucleosides, free bases, 
urate. Left to right; adenine and derivatives, inosine 
and derivatives, xanthine and derivatives, guanine and 
derivatives. 
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dependent in each case. IMP reacts with aspartate 
and GTP catalysed by IMP : L- aspartate ligase (GTP) 
EC 6.3.4.4 to form adenylosuccinate; fumarate is 
removed from this compound by the action of 
adenylosuccinate : AMP ligase EC 4.3.2.2 to produce 
AMP. 
IMP also reacts with NAD+ and water catalysed 
by IMP : NAD+ oxidoreductase EC 1.2.1.14 to form XMP; 
this compound reacts with glutamine and ATP catalysed 
by XMP : L- glutamine amidoligase (AMP) to generate 
GMP. This system can be seen to exert a cross -over 
control whereby the production of AMP requires a GTP 
driven reaction and the production of GMP requires an 
ATP driven reaction; the flow through one of the 
two pathways is controlled by the concentration of a 
metabolite of alternate branch of the system. 
The end products AMP and GMP may be reduced to 
2 -deoxy AMP and GMP for DNA biosynthesis (Blakley and 
Vitols, 1968) . 
5'- Mononucleotides are dephosphorylated by 
5'- ribonucleotide phosphohydrolase EC 3.1.3.5 to the 
corresponding nucleosides. The resultant nucleosides, 
inosine, xanthosine, and guanosine can be degraded to 
the corresponding free bases by the action of 
nucleoside : orthophosphate ribosyltransferase EC 2.4.2.a. 
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Adenosine is not a substrate for this enzyme 
(Huennekens, Nurk and Gabrio, 1956a), but a 
report by Zimmerman, Gersten and Miech (1970) 
claimed to have detected a slow reaction with this 
substrate. 
3'- Mononucleotides resulting from the 
hydrolysis of RNA (Sugar and Sierakowska, 1967) can 
be dephosphorylated by non -specific phosphatases 
EC 3.1.3.1 and EC 3.1.3.2, to guanosine or adenosine. 
The resulting guanosine can be degraded to free 
guanine which can be recycled to GMP by HGPRTase. 
Adenosine can be phosphorylated to AMP by ATP 
adenosine -5'- phosphotransferase EC 2.7.1.20 or may 
be deaminated to inosine by adenosine aminohydrolase 
EC 3.5.4.4. The resultant inosine can be degraded 
to hypoxanthine which can also be recycled by HGPRTase 
to yield IMP. 
Earl Balis (1968) has proposed a cyclical 
interconversion of purines involving the sequence 
IMP -_ AMP - adenosine -p inosine . hypoxanthine IMP. 
The mechanism adenosine -- inosine .-:io. hypoxanthine 
has been demonstrated in guinea pig brain by Shimizu, 
Tanaka and Kodama (1972) . 
The principal pathway of uric acid production 
is guanine -> xanthine -j urate (Sorensen, 1970) , and 
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the most probable purine for salvage by HGPRTase 
is hypoxanthine resulting from the catabolism of 
adenine derivatives. 
Murray, Eliot and Atkinson (1970) have reviewed 
the enzymology of purine interconversions. 
This system of purine interconversion ensures 
adequate supplies of nucleotide precursors for 
normal growth by a "self balancing network of enzymic 
reactions "(Murray, Eliot and Atkinson, 1970). 
1.7 ROLE OF 5'- PHOSPHORIBOSYL -1- PYROPHOSPHATE 
PRPP is a common substrate for both de novo purine 
biosynthesis and for salvage synthesis from the free 
bases hypoxanthine and guanine. It is also a 
substrate for several other enzymes, including orotate 
phosphoribosyltransferase EC 2.4.2.10, a key enzyme 
in pyrimidine nucleotide biosynthesis. Some of the 
other enzymes involved in the catabolism of PRPP are 
shown in Fig. 5, and many anti- tumour drugs are also 
substrates for the enzymes. 
The central role of intracellular PRPP 
concentrations in the regulation of de novo purine 
biosynthesis is shown by the depletion of PRPP levels 
in tissue culture cells by orotic acid resulting in 
decreased de novo purine biosynthesis (Kelley, Fox and 
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Wyngaarden, 1970), and similar results have been 
obtained in vivo (Kelley et al., 1970). 
Fox and Kelley (1971) have suggested that as 
the range of intracellular PRPP concentrations are 
lower than the Km values for most other PRTase 
enzymes, this substrate may be generally rate limiting. 
Patients with primary gout and partial HGPRTase 
deficiency were found to have elevated erythrocyte 
PRPP concentrations by Greene and Seegmiller (1967), 
and PRPP turnover rates were shown to be increased 
in three gouty patients (Jones, Ashton and Wyngaarden, 
1962) . 
Greene and Seegmiller (1969) also found 
elevated PRPP concentrations in erythrocytes from 
seven patients with the Lesch -Nyhan syndrome. 
It is possible that in Lesch -Nyhan patients, 
due to the lack of HGPRTase, PRPP concentrations rise 
and AMP and GMP concentrations fall. As a result of 
the lack of inhibition of PRPP amidotransferase by 
AMP and GMP and the rise of PRPP concentrations, 
de novo purine biosynthesis can increase. There are, 
however, some difficulties in this theory; if de novo 
purine biosynthesis increases to compensate for the 
failure of the salvage pathway, then AMP and GMP 
concentrations should rise and PRPP concentrations fall 
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until the normal equilibrium state is reached. 
This does not occur in patients with the Lesch- 
Nyhan syndrome, where de novo synthesis, as 
estimated by uric acid excretion, is as much as 
twenty times greater than normal. This may 
suggest that other factors in addition to increased 
intracellular PRPP concentrations are operating to 
increase de novo purine biosynthesis in these patients 
and to pull the equilibrium of the system towards 
catabolic processes. 
1.8 ROLE OF THE PRTases IN DRUG METABOLISM 
Many anti -tumour drugs exert their effects at 
the nucleotide or nucleotide triphosphate level. As 
nucleotides do not cross cell membranes to any extent 
(Davis, 1958), these compounds are administered as 
the free bases, for example 6- mercaptopurine and 
6- thioguanine. These drugs are converted to their 
active nucleotide form by HGPRTase to 6 -thio IMP and 
6 -thio GMP (Brockman, 1960) and function as analogs 
of IMP and GMP. Since 6- mercaptopurine has a Km of 
11 /LIM with HGPRTase (Atkinson and Murray, 1965) this 
drug is a powerful competitive inhibitor of HGPRTase. 
In this active nucleotide form these drugs inhibit the 
interconversions of purine nucleotides and the formation 
2o. 
s 
of nucleo) ide triphosphates, and hence exercise 
their control on growth by starving the cells of 
nucleotide triphosphate precursors for nucleic acid 
synthesis. It is likely that tissues with high 
HGPRTase activity which depend on hypoxanthine as 
a source of nucleotides will show a high sensitivity 
to these drugs. 
SECTION II 
MATERIALS AND METHODS 
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2.1 MATERIALS 
All general laboratory chemicals were purchased 
ANALAR grade from British Drug Houses Ltd., Poole, 
Dorset. 
Radiochemicals were purchased from The 
Radiochemical Centre, Amersham, Buckinghamshire. 
These were adenine-[8- 
14 
C] at> 50 ¡aCi 4umole, 
hypoxanthine- [8 -14C] 7 50 IuCi /flmole, adenosine- [8 -14C] 
5'-monophosphate, ammonium salt, 40 - 60 luCi /famole, and 
guanosine- [8- 14C]5'- monophosphate, ammonium salt 
30 - 50 flCi /fumole. The radiochemicals were chromato- 
graphically homogeneous using the system described in 
section 2.14. 
The following fine chemicals were purchased from 
Sigma Chemical Co. Ltd., Kingston, Surrey: adenine, 
hypoxanthine, guanine, adenosine, guanosine, inosine, 
AMP, IMP, GMP, 5' PRPP, TTP, Allopurinol, and 
6- mercaptopurine. All chemicals were of the purest 
grade available and were chromatographically 
homogeneous in the system described in section 2.14 
with the exception of adenine. Adenine had a fast 
moving impurity with an Rf of 0.6. PRPP was 90% pure, 
the major impurity being ribose -5- phosphate. 
The following enzymes were also purchased from Sigma:- 
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5'- Nucleotidase: EC 3.1.3.5 Grade II from 
Crotalus adamanteus venom. 
Deoxyribonuclease: DN -EP. Electrophoretically 
purified from beef pancreas. 
Ribonuclease T2: from Aspergillus mould. 
Protease: Type VI from Streptomyces griseus 
and also 
DNA: Type I from calf thymus. 
RNA: Type II from Torula yeast. 
The liquid scintillators, NE 233, and Bray's 
solution were supplied by Nuclear Enterprises Ltd., 
Edinburgh. 
Bovine serum albumin was supplied by Koch -Light 
Ltd., Buckinghamshire. 
Kodak AR 10, Kodak D 19, Kodafix, and Depex, used 
in the autoradiography were obtained from Eastman- 
Kodak Inc., Kirkby, Liverpool. 
2.2 PREPARATION OF TISSUES FOR ENZYME ASSAYS 
2.2a Red Cell Lysates 
Whole fresh venous blood, stored in lithium 
heparin tubes, was obtained from patients directly or 
through the Department of Haematology, Royal Hospital 
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for Sick Children, and from volunteers. 
The erythrocytes were separated from the buffy 
coat of leucocytes and plasma after centrifugation 
at 3000 g for 5 min. The erythrocytes were washed 
twice with five volumes of isotonic saline, and 
separated by centrifuging at 3000 g for 5 min. 
A 100 lal sample of packed erythrocytes was 
lysed in 900 fIl of deionised water, mixed and left 
for 5 min. at 4 °C. After this time, the stroma 
was removed by centrifuging at 10,000 g for 10 min. 
The lysate was dialysed for 1 h against 1 litre of 
distilled water to remove endogenous substrates, and 
a sample of the dialysis residue used for the PRTase 
assays. 
2.2b Tissue Homogenates 
All procedures were carried out in a cold room 
at 4°C. 
Approximately 1 g of tissue was washed in 20 ml 
of 220 mM Tris /HC1 buffer pH 7.4, cut into small 
pieces, and homogenised using a motor driven Teflon 
homogeniser (Jencons) at 2000 r.p.m. for about 30 sec. 
Five passes of the homogeniser were used. The 
resulting homogenate was centrifuged at 26,000 g 
for 1 h at 4 °C. The supernatant was carefully removed 
by Pasteur pipette, then dialysed for 1 h against 
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1 litre of distilled water to remove any 
endogenous substrate. A sample of the dialysis 
residue was used for enzyme assays. 
2.2c Trypsinisation of Tissue Culture Monolayers 
Fibroblasts and amnion cells grown in tissue 
culture were harvested as follows: the tissue 
culture medium was poured off, and the cell monolayer 
washed twice with isotonic saline. 
10 ml of trypsin solution (2.5 mg protein /ml) 
and 10 ml of 20 mM ethylenediaminetetraacetic acid 
(E .D .T .A.) were added and left for 20 min. at room 
temperature with occasional gentle shaking to help 
detach the cells from the glass. 
The cell suspension in trypsin /EDTA was poured 
off into a centrifuge tube, and an equal volume of 
foetal calf serum in Ham's F10 tissue culture medium 
added. 
The cells were separated by centrifuging at 
10,000 g for 10 min. at 4 °C. 
The cell pellet was washed by resuspending the 
cells in 10 ml of 220 mM Tris /HC1 buffer pH 7.4 and 
separated by centrifuging as above. 
The washed cell pellet was homogenised as described 
in the procedure for the preparation of tissue 
homogenates. 
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2.3 ASSAY OF PURINE PHOSPHORIBOSYLTRANSFERASES 
Hypoxanthine guanine phosphoribosyltransferase 
(HGPRTase) [IMP : Pyrophosphate phosphoribosyl- 
transferase EC 2.4.2.8]and adenine phosphoribosyl- 
transferase (APRTase) [AMP : Pyrophosphate 
phosphoribosyltransferase EC 2.4.2.7] activities 
were assayed by a modified method of Cartier and 
Hamet (1968). This method involves the use of 
radiochemical substrate purines, and the separation 
of the unchanged substrate from the polyanionic 
product by ion exchange chromatography on diethyl - 
aminoethyl (DEAE) paper. 
However, this method and others, see Chow, 
Kawahara, Saunders and Sorensen (1970), Fujimoto, 
Greene and Seegmiller (1968) and Krenitsky, Papaioannou 
and Elion (1969) are unsuitable for tissues other 
than erythrocytes because enzyme assays carried out 
on crude tissue homogenates are complicated by the 
product of the system under investigation being a 
substrate for another enzyme present. 
5'- mononucleotides are substrates for the widely 
distributed 5'- nucleotidase (5'Nase) [EC 3.1.3.5] 
(see Bodansky and Schwartz, 1968), and hence the 
products of the PRTase reactions are degraded to 
nucleosides in the presence of 5'Nase. 
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Thymidine triphosphate (TTP) is an 
inhibitor of 5'Nase (Murray and Friedrichs, 1969), 
and by the addition of this compound to the PRTase 
assay system, erroneously low results due to 
product breakdown are largely eliminated. TTP 
was therefore added to the assay system to a final 
concentration of 1.5 mM. The inhibitory effects 
of TTP are maximal at 1.1 mM and remain constant 
with increasing concentrations (Murray and Friedrichs, 
1969) . 
A further modification from the procedure of Cartier 
and Hamet (1968) was the scaling down of the 
reaction volume by a factor of two for economic 
reasons due to the high cost of 5'- phosphoribosyl- 
1- pyrophosphate (PRPP). 
Assay procedure The radioactive substrates 
adenine- [8 -14C] and hypoxanthine- [8 -14C] were 
diluted for use by the addition of the appropriate 
unlabelled base to give a specific activity of 0.75 
f1Ci /mM. 
All additions and removal of components were 
made by Hamilton microsyringe: when a large number 
of determinations were being carried out, the assay 
medium was prepared in bulk and dispensed into assay 
tubes to minimise pipetting error. 
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The assay medium was of the composition 
shown in Table I. 
75 pl of the assay medium were dispensed into 
glass tubes 50 x 6 mm and preincubated for 5 min. 
in a water bath at 37 °C 1 °. Timing of the 
reaction commenced following the rapid addition of 
25 pl of the enzyme sample. The reaction was 
allowed to proceed for between five and thirty 
minutes depending on the tissue being investigated, 
before being halted by the addition of 25 2l of 100 mM 
EDTA with subsequent chilling in an ice bath at 3 °C. 
30 Iul samples of the reaction mixture (total 
volume 125 fal) were applied to a DEAE paper strip as 
a 5 mm band at 60 mm from one end. The DEAE paper 
was 150 x 15 mm and is shown in Fig. 6. 
The chromatogram was developed for 100 min. by 
descending chromatography using a solvent of 95% 
ethanol; 1M ammonium acetate pH adjusted to 3.8 with 
acetic acid, 70 : 35 v /v, as described by Paladini 
and Leloir (1952) . 
After oven drying the chromatogram for 30 min. 
it was cut into two sections for counting; section A, 
-5 to +40 mm (Fig. 6) having bound all the nucleotide 
product, and section B, +40 to +90 mm binding the 
faster migrating unreacted substrate. Chromatographic 
TABLE I 
THE ASSAY MEDIUM FOR THE ESTIMATION 







Tris /HC1 buffer pH 7.4 220 25 55 
Magnesium chloride 50 10 5 
PRPP - Mg2 or Na4 10 10 1 
TTP - Na2 30 5 1.5 
Adenine- [8 -14C] 
2.4 25 0.6 
Hypoxanthine- [8 -14C] 
Enzyme - 25 - 
15mm 






60 mm ORIGIN 
150 mm 
DIMENSIONS OF DEAE PAPER CHROMATOGRAM SHOWING 
AREAS USED FOR LIQUID SCINTILLATION COUNTING 
Fiq. 6 
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reproducibility was checked using mixtures of 
unlabelled bases and nucleotides which were 
separated using the above system; the mobilities were 
determined by visualising the bands using a low 
pressure ultraviolet lamp maximum emission 254 nm. 
Dark bands were visible against a slightly 
fluorescent background. 
For each chromatographic run, three control 
chromatograms were developed to correct for activity 
due to slow running purines. In place of the 
enzyme sample 25 pl of water was added to an assay 
tube with 75 rl of the assay medium and 25 111 of 
100 mM EDTA. Aliquots of 30 rl from the control 
assay were applied to the control chromatograms 
which were developed at the wall edges and centre of 
the solvent tray. 
From these control chromatograms the mean of 
the counts from section A (Fig. 6) was subtracted 
from the counts in the assay chromatogram to correct 
for counts due to slow migrating substrate. 
The enzyme activity was calculated as follows:- 
Counts from product AMP or IMP 
(Section A) 
Counts from substrate Adenine - 
14 14 





Counts from slow running substrate 
(control section A) = Cc 
The per cent transformation of substrate 
is given by 
%T = 
Cp - Cc 




Enzyme activity was expressed as nmole of 
substrate transformed per hour and related to total 
protein determined as described in section 2.5. 
Where possible enzyme activities were determined 
in duplicate. 
Example of calculation 
Cp = 11,000 Time of incubation = 10 min. 
Cs = 89,000 Enzyme sample 5 mg protein /ml 
Cc = 500 
%T = 
11,000 - 500 
x 
100 = 10.5% 
11,000 + 89,000 1 
mmoles of substrate in assay medium = 62 
10.5 x 0.62 = 6.51 nmoles substrate transformed 
6.51 x 60 = 39.06 nmoles/h 
10 
Protein in enzyme sample = 5.0 dug / /l. 
volume of sample = 25 µl. 
total protein = 125 rg. 
30. 
nmole substrate transformed/h /mg protein 
= 39.06 x 1000 = 312.48 
125 
Result 312.48 nmole/h /mg protein. 
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2.4 LIQUID SCINTILLATION COUNTING IN TWO PHASE SYSTEMS 
The radioactivity on the separate sections of 
the DEAE ion exchange paper was counted directly in 
a two phase system (Davidson, 1961), using a Packard 
Tricarb model 2002 liquid scintillation counter. 
Settings for [14C] were as follows, Gain 8 %, Window A--B 
with A = 50 and B = 1000. 
Each section of DEAE paper was cut into four 
pieces 7.5 x 25 mm (Fig. 7) and these were placed in 
parallel walled glass vials 12 x 50 mm to which 3.0 ml 
of liquid scintillator NE 233 was added. This method 
was adopted to economise in the use of scintillator, 
3.0 ml compared to 10 ml, but also had the advantage 
of ensuring a regular geometric presentation of the 
sample to the photomultiplier tubes. The vials were 
then sealed with plastic caps, and placed in the Packard 
vials and at least 5000 counts recorded. 
The counting efficiency was determined by the 
method of internal standardisation (Rogers and Moran, 
1966) using hypoxanthine- [8 -14C] and found to be 49 %. 
Duplicate samples and single samples counted a number 
of times were highly reproducible with a coefficient of 
variation of less than 1 %. 
2.5 DETERMINATION OF TOTAL PROTEIN 

















(A) METHOD OF CUTTING OF DEAE PAPER FOR LIQUID SCINTILLATION COUNTING 
(B) COUNTING VIAL FOR DEAE PAPER 
Fig. 7 
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modification of the method of Lowry et al. (1951). 
The copper reagent was prepared for each batch 
of determinations, and a standard graph prepared of 
20, 40, 60, 80 and 100 lug of bovine serum albumin per 
ml. The optical density was determined at 680 nm 
using a Pye Unicam SP 500 spectrophotometer. 
2.6 ASSAY OF 5'- NUCLEOTIDASE 
5'- nucleotidase (5'Nase) EC 3.1.3.5 was assayed 
under conditions identical to those used for the purine 
phosphoribosyltransferases except that TTP was omitted. 
The present conditions of assay were designed to 
determine the degree of underestimation of measured 
PRTase activity due to the breakdown of the product 
nucleotide by 5'Nase. The conditions of assay were not 
therefore necessarily optimal such as those described 
by Bodansky and Schwartz (1968) or Belfield and Goldberg 
(1969) . 
The radioactive substrates adenosine- [8 -14C] 
monophosphate and inosine- [8 -14C] monophosphate were 
diluted for use by the addition of the appropriate 
unlabelled nucleotide to a specific activity of 1.0 pCi /mmole. 
All additions and removal of components were made 
using a Hamilton microlitre syringe. When a large 
number of determinations was being carried out, the 
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the assay medium was prepared in bulk and 75 µl 
dispensed to each assay tube. The assay medium 
contained the components shown in Table II. 
The assay tubes 50 x 6 mm containing 75 it of 
the assay medium were preincubated in a water bath 
at 37o -F lo for 5 min., and timing of the reaction 
commenced with the addition of 25 µl of the enzyme 
sample. 
The reaction was allowed to proceed for 15 min. 
before being halted by the addition of 25 µl of 10% v/v 
trichloroacetic acid (TCA). The precipitated protein 
was removed by centrifuging on a bench centrifuge at 
1000 g for 5 min. A 30 rl sample of the supernatant 
was added as a 5 mm band to the origin at 60 mm from 
one end of a DEAE paper strip. This chromatogram was 
developed for 100 min. by descending chromatography 
using a solvent of 95% ethanol; 1M ammonium acetate adjusted 
to pH 3.8 with acetic acid; 70 : 35 v /v. 
After oven drying the chromatogram for 30 min., 
the strip was cut into two sections for counting: 
section A (Fig. 6) -5 to +40 mm bound all the unreacted 
substrate AMP or GMP due to the polyanionic phosphate 
group. The reaction product, adenosine or guanosine 
migrated to section B, +40 to +90 mm from the origin. 
The chromatographic mobilities of both substrate 
TABLE II 
ASSAY MEDIUM FOR ESTIMATION OF 








Tris /HC1 buffer pH 7.4 220 25 55 
Mg C12 50 lO 5 
AMP- [8 -14C] 
2.4 25 0.6 
GMP- [8 -14C] 
Water - 15 - 
Enzyme - 25 - 
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and product were checked by developing mixtures of 
unlabelled nucleotides and nucleosides which were 
located by their absorption of ultraviolet light. 
For each group of assays, three control 
chromatograms were developed to correct for any fast 
migrating nucleotides. 25 pl of water was added to 
the assay medium in place of the enzyme sample and 
25 rl of 10% v/v TCA. 30 µl samples were applied to 
the control chromatograms and developed at the wall 
edges and centre of the solvent tray. From these 
control chromatograms the mean of the counts from 
section B was subtracted from the counts due to the 
product from the assay chromatograms to correct for 
fast migrating nucleotides. 
The enzyme activity was calculated as follows : - 
Counts from product adenosine or 
guanosine (section B) 
Counts from substrate AMP or GMP 
(section A) 
Counts from fast migrating substrate 




The per cent transformation of substrate is 
given by :- 
%T - 
Cp - Cc 100 




Enzyme activity was expressed as nmole of 
substrate transformed per hour and related to total 
protein. Where possible, enzyme activities were 
determined in duplicate. 
Example of calculation 
Cp = 8,500 Incubation time = 15 min. 
Cs = 91,500 Enzyme sample 7.5 mg /ml protein 
Cc = 500 
8 500 - 500 100 
%T 
8,500 + 91,500 1 
= 8.0% 
nmole of substrate in assay medium = 63 
8.0% of 62 = 4.95 nmole substrate transformed 
= 19.8 nmole/h 
Protein in enzyme sample = 7.5 '.a.g /dal 
Volume of sample = 25 fa 
. total protein 188 Iu.g 
nmole substrate transformed /h /mg protein 
= 19.8 x 
1880 - 
105 
Result 105 nmole/h /mg protein 
2.7a Electrophoresis of Purine Phosphoribosyltransferases 
h 
Electrophoresis oä cellulose acetate was carried 
out as described by Kohn (1969). Cellulose acetate 
strips (Millipore) 170 x 25 mm were used in a Shandon 
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horizontal electrophoresis tank using a barbitone 
buffer pH 8.6 of the following composition: sodium 
diethyl barbiturate 10.3 g and diethyl barbituric 
acid 1.84 g in 1 litre of water. 
The strips were floated on the surface of the 
buffer to ensure uniform moistening and, after soaking 
for 30 min., were blotted dry. They were then 
connected to the buffer compartment by paper wicks 
soaked in buffer, and a potential difference of 
5 volts /cm applied at a constant current of 2 mA. 
After 30 min. to allow for any electroendosmotic 
flow effect to reach a steady state, the sample of 
5 - 10 it was applied, using a microcapillary pipette, 
as a line, 15 mm from the end of the strip nearest the 
cathode. 
After 3 - 4 h electrophoresis, the haemoglobin 
band, if present, migrated 40 mm towards the anode. 
Strips were then removed from the tank using forceps 
and placed on a glass thin -layer chromatography plate. 
The bands of PRTase activity were located as described 
in the following section. 
Electrophoresis of the PRTases was also carried out 
in starch gel. The gel was prepared and poured as 
described by Bodman (1969) using the gel buffer of 
Smithies (1955). The starch gel in the perspex gel former 
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(Shandon) 50 x 185 mm was laid across the supports 
in a Shandon horizontal electrophoresis tank and 
connected to the buffer tanks by wicks of Whatman No. 1 
paper soaked in reservoir buffer (Smithies, 1955). 
A potential difference of 5.4 volts /cm was 
applied at a constant current of 2.0 mA and the gel 
allowed to equilibrate with respect to buffer flow for 
1 h. 
The most satisfactory technique of sample 
application to attain high resolution was achieved as 
follows: a 30 it sample was absorbed on to a piece of 
Whatman No. 1 paper 20 x 4 mm and inserted using 
forceps into a slit of similar dimensions cut into the 
gel 15 mm from the cathodic end. The slit was sealed 
with a silicon greased microscope cover slip, and the 
entire gel covered with a thin sheet of polythene to 
prevent the gel drying as a result of evaporation. 
After electrophoresis for 20 h, the haemoglobin 
band, if present, migrates 5 - 6 cm towards the anode. 
Following electrophoresis, the gel was removed 
from the former and sliced into two layers using a 
Shandon gel slicer. The lower layer was transferred 
to a glass thin layer chromatography plate and the bands 
of PRTase activity located as described in the following 
section. 
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2.7b Location of Purine Phosphoribosyltransferase 
Activity in the Electrophoresis Support Medium 
The bands of PRTase activity in the electro- 
phoresis support medium were located at its surface 
by placing a marked strip of DEAE ion exchange paper 
saturated with PRTase reaction medium in contact with 
it. Zones of PRTase activity in the electrophoresis 
support convert the radiochemical substrate base on 
the DEAE paper into the charged product nucleotides. 
The strip of DEAE paper 150 x 15 mm marked off in 
1 cm units was moistened with 500 rl of a medium of 
composition shown in Table III. 
The detection medium is essentially identical to 
the assay medium with water added in place of enzyme 
sample. This addition adjusts the molarities to those 
in the assay system, while the enzyme is immobilised in 
the solid phase on the support medium. The moist 
DEAE paper was laid over the electrophoresis support 
medium with the first centimetre on the paper opposed to 
the first centimetre of the origin on the support medium. 
This unit was then sandwiched between two glass thin - 
layer plates which were lightly clamped together with 
spring clips. The assembly was incubated for 3 h in 
the moist atmosphere provided by a lidded water bath. 
The temperature of this atmosphere was 37 °C. At the end 
TABLE III 







Tris /HC1 buffer pH 7.4 220 125 55 
Mg C12 50 50 5 
PRPP - di Mg. 10 50 1 
Adenine- [8 -14C] 
2.4 125 0.6 
Hypoxanthine- [8 -14C] 
Water - 150 - 
of this period, the DEAE paper was carefully lifted 
off the surface of the support medium, and washed 
with slow magnetic stirring for 4 h in 4 1 of 8 mM 
tris buffer pH 9.5. During the wash, the unreacted 
substrate was removed from the DEAE paper while the 
charged nucleotide products of PRTase activity were 
tightly bound by the anionic exchange groups. The 
paper was oven dried for 30 min., cut into 1 cm 
sections and counted. The peaks of radioactivity due 
to the products of PRTase activity, AMP or IMP, 
indicated the position of the bands of PRTase activity 
in the electrophoresis support medium. 
Although this method has not yet provided the 
high resolution reported by Bakay and Nyhan (1971) who 
used 1.5 mm slices of polyacrylamide gel, it is 
considerably easier to perform and represents an 
improvement on previously published methods (Kaloustian 
et al., 1969). Since this work has been completed a 
number of authors have described similar methods. 
2.7c Confirmation of the Identity of Regions of 
Radioactivity, Corresponding to PRTase Activity 
in the Electrophoresis Support Medium 
As four distinct peaks of radioactivity were 
detected, indicating four bands of PRTase activity which 
conflicted with previous reports of one band (Atkinson 
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and Murray, 1965; Kelley et al., 1969; Kaloustian 
et al., 1969), it was necessary to establish that the 
activity was due to the products of PRTase activity. 
This was achieved by using DEAE paper moistened with 
a modified assay medium. This medium contained either 
EDTA to complex the Mg +2 ion essential for the PRTase 
reaction, or 6- mercaptopurine, a specific inhibitor of 
the reaction (Ki = 0.0039 x 103)(Krenitsky, 
Papaioannou and Elion, 1969) . 
The assay medium contained the components shown in 
Table IV. 
In the presence of 40 mM EDTA no peaks of activity 
were detected whereas four were detected in a control. 
When 6- mercaptopurine was present in the assay 
medium, peaks of radioactivity were reduced by 90% 
compared to a control. 
To determine if the peaks of radioactivity were 
due to 5'AMP or 5'IMP, a DEAE strip was halved 
longitudinally subsequent to assay. One half was 
treated for 2 h with 500 f.11 of 5'- nucleotidase in 
220 mM tris/HC1 buffer pH 7.4 (1 mg protein /ml) above 
a water bath with a moist air temperature of 37°C. 
Both halves of the DEAE were then washed and counted 
as described in section 2.4. 
No peaks of radioactivity were detected in the half 
TABLE IV 








Tris /HC1 buffer pH 7.4 220 125 55 
Mg C12 50 50 5 
PRPP di Mg. 10 50 1 
Adenine- [8 -14C] 
2.4 125 0.6 
Hypoxanthine- [8 -14C] 
EDTA or 200 100 40 
6- Mercaptopurine 3.5 f1M 100 0.7 f-1M 
4.L. 
treated with 5'- nucleotidase. As 5'- nucleotidase 
is specific to 5'- mononucleotides (Bodansky and 
Schwartz, 1968) it was concluded that the peaks of 
radioactivity were due to 5'- nucleotides. 
2.8 DETERMINATION OF SPECIFIC REACTION RATE CONSTANTS 
FOR THERMAL DENATURATION OF PURINE PHOSPHORIBOSYL- 
TRANSFERASES 
Dialysed samples of red cell lysates or tissue 
homogenates were diluted to a protein concentration 
of 5 mg /ml by the addition of 220 mM tris /HC1 buffer 
pH 7.4. The enzyme sample was incubated, with shaking, 
in 100 x 10 mm thin walled glass tubes. A temperature 
of 80 °C 1° was used for the denaturation of HGPRTase, 
and 56 °C -F 1 °C was employed for the denaturation of 
APRTase (Kelley et al., 1969) . 
Aliquots of 25 ,l were removed prior to incubation 
to determine initial PRTase activity. Further 25 r1 
samples were removed after 2, 4, 6 and 8 min. incubation 
and the residual PRTase activity determined. Results 
of the assays were expressed as a percentage of the 
initial PRTase activity. 
Plotting the logarithm of the percentage residual 
PRTase activity against time of incubation consistently 
yielded straight lines. The rate of denaturation of 
the PRTases under the defined conditions was thus 
found 
4L . 
to approximate to first order unimolecular reaction 
kinetics. Fitting the experimental data to second 
or third order rate equations showed that these 
treatments were inapplicable (Glasstone and Lewis, 
1960) . 
The first order rate equation is 
k = 1 
Co 
t C 
Egn . 1 
where k is the specific reaction rate constant; Co 
is the initial concentration of the reactant (PRTase); 
and C is the concentration of catalytically competent 
PRTase at subsequent time t. A more useful form of 
equation 1 can be obtained by assuming that "a" moles 
of the reactant (100 %) are initially present and that 
"x" is the number of moles that will have reacted after 
time t, leaving a - x unreacted. Thus, Co is 














10 a Eqn. 3 
and a - x as defined is equal to the percentage 
residual 
activity and is a pure number without units. 








(a - x) Eqn. 4 
so that plots of t against log10 (a - x) will be 
linear for first order reactions, the slope of the 
line being equal to -2k303. This enables the specific 
reaction rate constant k to be evaluated. The 
constant k has the dimensions of reciprocal time. 
2.9 DETERMINATION OF APPARENT MICHAELIS CONSTANTS 
Apparent Michaelis constants (Km) and maximal 
velocities (Vmax) for adenine and hypoxanthine in 
their respective systems were obtained by determining 
initial velocities from a series of substrate 
concentrations. Excess of the second substrate PRPP, 
and optimal Mg +2 concentrations were present in the 
assay medium. 
Purine substrates were prepared initially at 
approximately 1 mmolar with a specific activity of 
20 rCi /Inmole. The precise molarity was determined 
spectrophotometrically using a Pye S.P. 500 ultraviolet 
spectrophotometer and the following data:- 
Adenine: absorption maximum at 262.5 nm pH 1 -3, 
with a molar absorptivity of 13.5 x 103. 
 
Hypoxanthine: absorption maximum 248 nm at 
pH 1.0, with a molar absorptivity 
of 10.8 x 103. 
Standards thus prepared were diluted with 
distilled water to give the range of substrate 
concentrations required for kinetic studies. For 
APRTase the concentrations of adenine used were 0.5, 
1.0, 2.0, 5 and 10 1M, and for HGPRTase the 
concentrations of hypoxanthine used were 2, 4, 8, 16 
and 32 rM. Red cell lysates or tissue homogenates 
prepared as described in section 2.2 were diluted 
twenty times with distilled water, and dialysed for 
12 h against 10 litres of water to remove any endogenous 
substrates and possible inhibitors. The dialysis 
residue was used directly for kinetic studies. 
Prior to determining initial velocities at varying 
substrate concentrations, the linearity of both time 
of incubation and volume of enzyme sample against mass 
of substrate transformed were checked. The method of 
assay was similar to that described in section 2.3 
except that a control chromatogram was developed for 
each substrate concentration used, and the counts from 
this control subtracted from the counts in the assay 
chromatogram. A major alteration was a reduction of 
the incubation time from 15 min. to 90 sec. 
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Km and Vmax values were obtained by entering 
the experimental data into an Olivetti Programma 101 
desk top computer. This was programmed to calculate 
Km and Vmax from a regression line of the experimental 
points for Lineweaver -Burk and Hofstee -Eadie plots. 
The programmes were written by Dr t1 Nimmo, 
Department of Biochemistry, University of Edinburgh. 
2.10 HISTOLOGICAL LOCALISATION OF HYPDXANTHINE GUANINE 
PHOSPHORIBOSYLTRANSFERASE USING AUTORADIOGRAPHY 
Human tissues were obtained at necropsy within 
twelve hours of death. Portions of testis, cerebral 
cortex, and thyroid gland were divided into cubes of 
approximately 2 mm face. The fragments were placed 
on tantalum wire grids (Trowel, 1959) and placed in 
Trowel's T8 organ culture medium with added [3H] -hypoxanthine 
(specific activity 1.0 Ci /mmole). Fragments were 
also placed free in the medium. The tissue was 
incubated for 2 h at 37oC, and after this time the 
fragments were washed three times with Hank's basic 
salt solution before being fixed in 10% neutral 
formalin. The material was then paraffin processed, 
sections cut at seven microns and stained with 
haematoxylin. 
Autoradiographs were prepared using Kodak AR 10 
stripping film and an exposure period of twenty -eight 
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days. The film was developed with Kodak D19, 
fixed in 12.5% Kodafix and mounted in Depex. 
This work was carried out in collaboration 
with Dr J.M. Anderson, Department of Paediatric 
Pathology, The Royal Hospital for Sick Children, 
Edinburgh. 
2.11 DETERMINATION OF THE SUBCELLULAR DISTRIBUTION OF 
HYPDXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 
ACTIVITY 
All procedures were carried out in a cold room 
at 4°C. 
Approximately 1 g of tissue was homogenised in 
8 ml of 220 mM tris /HCl buffer pH 7.4. Six passes of 
a Teflon homogeniser driven at 2000 r.p.m. were used. 
An aliquot of the homogenate was twice frozen and 
thawed and used to determine total HGPRTase activity. 
The remainder of the homogenate was filtered through 
glass wool and further separated by centrifugation 
procedures. All volumes were noted throughout the 
following stages. The nuclei and cell debris were 
removed by centrifuging at 3,300 g for 10 min. at 4 °C. 
The mitochondrial fraction was separated by 
centrifuging at 17,000 g for 1 h at 4 °C, and the 
microsomal fraction by centrifuging at 105,000 g for 
5 h at 4°C. 
47. 
Determinations of HGPRTase activity were 
carried out on all the supernatant fractions and 
the total activity of the fractions calculated. 
2.12 PURINE TRANSPORT 
2.12a Labelling of Rabbit Erythrocytes 
To demonstrate that erythrocytes have the 
capacity to transport purines between tissues in vivo 
it was necessary to load the rabbit red cell with 
labelled hypoxanthine. This purine was used as it 
has been shown to be an intermediate in purine 
metabolism and not an end product (Bradford et al., 
1968) and is the major purine released by erythrocytes 
(Jorgensen and Poulsen, 1955) . 
Hypoxanthine passes into erythrocytes in vitro 
by a facilitated diffusion mechanism; it flows into 
the cell down a concentration gradient, and is 
converted intracellularly into IMP by HGPRTase; this 
enzyme has been shown to be essential for the uptake 
of purines by erythrocytes (Sperling et al., 1971) 
and may also be essential for the uptake of purines 
into other tissues. 
The charged phosphate group on IMP prevents the 
efflux of IMP from the cell, and the lowered intra- 
cellular hypoxanthine levels maintain the flow of 
extracellular hypoxanthine into the erythrocyte until 
48. 
equilibrium is attained. 
Four male New Zealand White rabbits were used. 
Allopurinol was administered, at 2, 4 and 10 mg/kg 
in experiments 2, 3 and 4 respectively. No 
allopurinol was administered in experiment 1. The 
drug was given as a suspension by a stomach tube, 
French Gauge 10. 
Allopurinol (4- hydroxypyrazolo (3,4- d)pyrimidine) 
is a competitive inhibitor of xanthine oxidase 
EC 1.2.3.2 and its administration delays the catabolism 
of hypoxanthine via xanthine to allantoin. Allopurinol 
has been shown to augment the incorporation of 
hypoxanthine into nucleic acids (Pomales et al., 1963). 
10 ml samples of whole blood were obtained by 
cardiac puncture and withdrawn via a 17 gauge needle 
into a syringe containing about 1000 units of free 
acid heparin. The blood was mixed and dispensed into 
a 50 ml Quickfit conical flask with a ground glass 
stopper. The purine, hypoxanthine-[8-14C] 50 IuCi- 
59 FCi4umole, was added to the 10 ml of blood in 
1 ml of a medium of the following composition, 
described by Mager et al. (1967): 100 /moles of 
glucose; 100 Fmole potassium phosphate pH 7.4; 10,000 
units of benzylpenicillin; 1 mg Streptomycin sulphate. 
The antibiotics were added to prevent bacterial growth 
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during the incubation procedure. The blood 
containing the hypoxanthine-[8-14C] and antibiotics 
was incubated for 2 h at 37 °C with gentle shaking, 
then centrifuged at 5000 g for 10 min. The 
supernatant was removed and stored at -4 °C. The 
packed cells were washed twice with five volumes of 
isotonic saline buffered with 0.01M potassium 
phosphate to pH 7.4. Washings were retained and 
stored at -4 °C. 
The washed, packed, cells were resuspended in 
2.5 volumes of isotonic saline and reinjected into 
the marginal ear vein of the donor rabbit. The 
hypoxanthine-[8-14C] added represented a 100% increase 
in the erythrocyte purine nucleotide concentrations, 
however, Mager et al. (1967) reported that similar 
increases did not affect the rate of efflux of 
hypoxanthine from the erythrocyte. 
After 4 h in experiment 1 and 45 h in experiments 
2, 3 and 4, the animal was killed by injecting 20 ml 
of air into the marginal ear vein. 
Tissues were removed as soon as possible, 
generally within 20 min. of death, and the nucleotide - 
containing fractions (acid soluble, RNA and DNA) were 
obtained by the procedures described in the following 
sections. 
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The procedures directly involving these 
rabbits were performed by Dr R. Dow, M.R.C. Brain 
Metabolism Unit, University of Edinburgh and 
Dr R.A. Harkness, Department of Paediatric Biochemistry, 
The Royal Hospital for Sick Children, Edinburgh. 
2.12b Extraction of Acid Soluble Nucleotides 
Acid soluble nucleotides were extracted from 
the excised tissues by homogenising 0.5 g of tissue 
in 10 ml of 0.2 M perchloric acid for 1 min. using 
an Ultraturrax homogeniser. 
The homogenate was centrifuged at 10,000 g for 
10 min. and the supernatant removed. 
Samples of the supernatant were counted as 
described in section 2.13 to determine the radio- 
activity in the acid soluble fraction. 
2.12c Preparation of Ribonucleic Acid 
RNA was extracted according to the procedure 
of Birnstiel, Sells and Purdom (1972). This 
procedure involves the treatment of homogenised 
tissue with phenol to remove the protein and DNA, 
and yields a DNA -free RNA preparation. 
The homogenising medium was of the following 
composition: 0.15M sodium chloride, 0.05M tris, and 
0.1% w/v sodium dodecyl sulphate (S .D . S) . 
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Immediately before use sufficient polyvinyl sulphate 
was added to the homogenising medium and sodium 
acetate to achieve a concentration of 2 flg /ml. Polyvinyl 
sulphate is reported to be an inhibitor of ribonuclease 
(Scherrer and Darnell, 1962). Phenol was prepared 
as a water saturated solution. Dilute saline citrate 
was prepared 0.015 M with respect to sodium chloride 
and 0.0015 M with respect to trisodium citrate. 
The following procedures were carried out in a 
cold room at 4 °C. 
Approximately 1 - 2 g of tissue were minced and 
washed with cold homogenising medium before blotting 
dry. The minced tissue was then homogenised in 20 ml 
of homogenising medium for about 1 min. using an Ultraturrax 
homogeniser at 20,000 r.p.m. to give a homogenate of 
smooth consistency. An equal volume of water saturated 
phenol was added and the mixture shaken for 30 min. in 
a bench shaker. The phenol emulsion was then broken 
by centrifuging at 10,000 g for 10 min. at 4 °C, and the 
supernatant containing the RNA removed by pipette. 
An equal volume of water saturated phenol was 
added to the supernatant and the mixture shaken as 
before. The phenol emulsion was broken by 
centrifuging at 10,000 g for 10 min. at 4 °C, the 
supernatant removed by pipette and sufficient sodium 
acetate added to achieve a concentration of 2% w/v at 






pH 5.0. The RNA was precipitated by the addition 
of 2 volumes of ice -cold ethanol and by storage 
overnight at -200C. The RNA was separated by 
centrifuging and the resulting pellet washed twice 
with absolute ethanol, and dissolved in dilute saline 
citrate solution. 
A standard graph was prepared of RNA in dilute 
saline citrate solution, at 10, 20, 30, 40 and 50 µg 
RNA per ml, and the optical density of these standards 
determined at 260 nm. 
2.12d Preparation of Deoxyribonucleic Acid 
DNA was extracted by a modified method of 
Marmur (1961). The method can be outlined as follows: 
the cells are first disrupted mechanically and by the 
action of the anionic detergent sodium dodecyl sulphate 
(S.D.S.); the cell debris, protein and fat removed by 
denaturation and centrifugation, RNA is removed by 
ribonuclease; this is followed by the selective 
precipitation of DNA with isopropanol. 
The homogenisation medium of 0.15 M sodium chloride, 
0.1 M EDTA pH 8.0 inhibits DNAase activity due to high 
pH or EDTA or both. Saline /citrate solution, 0.15 M 
sodium chloride, 0.015 M trisodium citrate maintains 
the ionic strength of the dissolved DNA and chelates 
divalent ions. The high concentration of sodium 
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perchlorate helps to dissociate the protein from 
the nucleic acid while the chloroform /isoamyl 
alcohol denatures protein and removes fat. The 
protein and fat move into the phenol layer and this 
is separated by centrifuging. 
Tissue homogenisation was carried out in a 
cold room at 4 °C; subsequent stages at room 
temperature. 
Approximately 2 g of tissue was minced, washed 
in saline /EDTA and blotted dry. The minced tissue 
was then homogenised in 20 ml of saline /EDTA for about 
30 sec. using an Ultraturrax homogeniser. A 5 ml 
aliquot of the homogenate was made 2% w/v with S.D.S. 
and incubated in a water bath at 60 0C for 10 min. If 
this preparation had the consistency of syrup, then 
the remainder was made 2% w/v with S.D.S. and incubated 
at 60 °C. If the 5 ml trial aliquot became lumpy on 
treatment with S.D.S. then the bulk of the homogenate 
was diluted by the addition of 10 ml of saline /EDTA 
before being made 2% w/v with S.D.S. and incubated as 
described. The incubated, S.D.S. -treated, homogenate 
was cooled to room temperature, made 1 M with respect 
to sodium perchlorate, and 1 /10 of the total volume (V1) 
of saturated Tris pH 8.0 added. 
This was followed by half a volume (v1/2) of chloroform/ 
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isoamyl alcohol 24 : 1 v /v, and a half volume (V2) 
of water saturated phenol. This preparation was 
mixed for 30 min. using a bench shaker, then 
centrifuged at 10,000 g for 10 min. The viscous 
supernatant containing the crude DNA was removed with 
a wide bore pipette, and DNA precipitated by the 
addition of two volumes of ice -cold ethanol. The 
DNA was then spooled onto a twisted glass rod, and 
the DNA fibres washed in turn with 90 %, 95% and 99.8% 
ethanol. The DNA was dissolved in 10 ml dilute 
saline /citrate solution (0.015 M sodium chloride 
0.0015 M trisodium citrate) and gently shaken to 
help dissolve the DNA. This solution was made to 
0.15 M sodium chloride, 0.015 M trisodium citrate by 
the addition of 1 ml of 1.5 M sodium chloride - 
0.15 M trisodium citrate solution. 
Impurities in the DNA preparation were removed 
by treatment with ribonuclease (RNase). 20 mg of 
RNase were dissolved in 1 ml of 2% w/v sodium acetate 
pH 5.0, and heated to 100°C for 5 min. to denature any 
deoxyribonuclease ( DNase) present. This DNase free 
RNase solution was added to the crude DNA preparation 
to give a RNase concentration of 50 ig /ml protein, and 
the mixture incubated at 37oC for 2 h. 
Protein was removed by treatment with protease 
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prepared from Streptomyces griseus at 20 mg /ml 
protein in saline /citrate solution. This was 
added to the DNA preparation to give a final 
concentration. of 400 fug /ml protein, and incubation 
was at 37oC for 3 h. 
After deproteinising, half of the total volume 
(V2) of chloroform /isoamyl alcohol and a half volume 
V2 
(2) of water saturated phenol were added, the 
mixture shaken and centrifuged as before, and the 
supernatant removed. 
The purified DNA was spooled onto a twisted glass 
rod after the addition of 2 volumes of propan-2 -ol 
and during the spooling a 1 /10th volume of sodium 
acetate /EDTA was added. The spool was washed in 
90 %, 95% and 99.8% ethanol and dissolved in 5 ml of 
0.015 M sodium chloride, 0.0015 M trisodium citrate. 
A standard graph was prepared of DNA in saline/ 
citrate solution at 10, 20, 30, 40 and 50 lug DNA /ml 
and the optical density of these standards determined 
at 260 nm. 
2.12e Determination of Purity of Prepared Deoxyribonucleic 
Acid and Ribonucleic Acid 
The possibility of DNA contamination of RNA was 
checked by the attempted digestion of the RNA samples 
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by DNase using the Sigma modification of the method 
of Kunitz (1950). 
The RNA contamination of DNA was checked by 
the attempted digestion of DNA samples with RNase 
using the method of Kunitz (1950). 
Both DNA and RNA were hydrolysed by DNase and 
RNase respectively using the above methods. 
2.13 LIQUID SCINTILLATION COUNTING OF AQUEOUS SAMPLES 
Aqueous samples were counted by the addition of 
100 t1 of the sample to 10 ml of Bray's solution 
(Bray, 1960) . 
The samples were counted in a Packard Tricarb 
liquid scintillation counter; settings were as 
before (section 2.4). 
The counting efficiency for 14C determined by 
internal standardisation was between fifty and sixty 
per cent. 
2.14 THIN LAYER CHROMATOGRAPHY OF PURINES AND PURINE 
DERIVATIVES 
Purines and derivatives were separated 
ci 
chromatographically using commer ally prepared 
cellulose plate 20 x 20 cm (Kodak, Ltd, Liverpool). 
Using a solvent of 1 M ammonium acetate pH 7.0 
(Hochstadt -Ozer and Stadturan, 1971) a running time of 
1 + 5 h gave satisfactory separations. The spots 
were identified under u/v light. 
TABLE V 
Rf VALUES FOR PURINES AND DERIVATIVES ON A SUPPORT OF 












RESULTS AND DISCUSSION 
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3.1 ERYTHROCYTE PURINE PHOSPHORIBOSYLTRANSFERASE 
3.1a Introduction 
Erythrocytes provide a readily available source 
of the purine phosphoribosyltransferases for both 
research and diagnostic purposes. 
These enzymes can be studied in erythrocytes 
by several methods, for example that of Fujimoto 
et al. (1968) or of Chow et al. (1970); the assay 
method developed in this work was based on that used 
for erythrocyte purine phosphoribosyltransferases by 
Cartier and Hamet (1968) . 
Initially, activities of both HG and APRTase 
from erythrocytes were determined to ensure that the 
assay system would yield results very similar to those 
obtained by Cartier and Hamet (1968). 
In an attempt to obtain maximal PRTase activity, 
the effects of the reducing agent sodium borohydride 
were investigated, since HGPRTase is known to be 
inhibited by the sulphydryl binder p- chloromercuri- 
benzoate (Krenitsky and Papaioannou, 1969). 
When there are -SH groups at the active site, 
the addition of a reducing agent to the enzyme assay 
medium often results in considerable increases in the 
measured activity (Adams, 1969). 
Modifications of the PRTase assay method 
The 
products of the PRTase reactions IMP, GMP and AMP, are 
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hydrolysed to nucleosides by 5 °- nucleotidase 
(EC 3.1.3.5) (Adams et al., 1971), an enzyme found 
in nearly all tissues except erythrocyte lysates. 
When the assay of the PRTases depends on the 
determination of the product nucleotide, a 
consequence of tissue 5 °- nucleotidase activity will 
be the reduction of nucleotide levels and hence 
underestimation of PRTase activity. In order to 
minimise this artefact, some potential inhibitors of 
5'- nucleotidase were studied. In agreement with 
the finding of Ahmed and Reis (1958), nickel ions were 
found to be powerful inhibitors of 5 °- nucleotidase; 
unfortunately nickel ions were found to also inhibit 
HGPRTase. The effects of thymidine triphosphate (TTP) 
as a selective inhibitor of 5'- nucleotidase (Murray and 
Friedrichs, 1969) were studied to determine its effects 
on HGPRTase, and TTP was shown to be an effective 
selective inhibitor of 5 °- nucleotidase. 
Relationship of HGPRTase activity to known 
alterations in urate excretion Cyclic changes in 
manic depressive illness are mirrored by changes in 
daily urinary uric acid excretion (Anumoyne et al., 
1968). Urinary urate is increased during the early 
phase of remission. These changes in urate excretion 
occur during natural remissions and remissions 
induced therapeutically by lithium carbonate. A 
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possible cause for the increase in urinary urate 
excretion could be an inhibition of GPRTase y 
lithium ions. A higher proportion of hypoxanthine 
might then be converted to xanthine and hence to urate. 
Therapy of manic depressive illness with 
lithium carbonate alms at plasma lithium levels of 
2 mMj, and the effect of 2 mM lithium on aGPRTase 
activity was therefore studied. 
The effects of testosterone at 5 and 10 iuM on 
:GPRTase activity were studied, as urinary excretion 
of urate falls and plasma urate levels rise til[ o rin o 
and after puberty (Harkness and Nicol, 1969) . It 
seemed possible that these changes could be related 
to increased testosterone levels. 
3.lb Results 
It was confirme that = -- _ of .- ..1 -yme in 
the incubation medium was ar1y related to the mass 
of substrate transforr increase in nmoles of 
hypoxanthine transformed per minute with increase in 
enzyme volume is shown in Fig - 8. This relationship 
was linear and remai.ne so with increase in enzyme 
volume up to a 25' transf=ation of substrate 
hypoxanthine (1.35 r.. -- protein) 
The effects of increasing ins.- -,__ ti.-.- on = -__ 
10 15 20 25 
AMOUNT OF ENZYME (u1) 
SUBSTRATE TRANSFORMED WITH INCREASE IN AMOUNT OF ENZYME (RED CELL) 
Fig. 8 
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mass of hypoxanthine transformed per minute, for 
a fixed volume of red cell lysate (25fil), are 
shown in Fig. 9. The relationship becomes non- 
linear after 25 min. incubation, but is linear up 
to twenty -five per cent transformation of substrate 
hypoxanthine. Similar results were obtained with 
erythrocyte APRTase. 
Sodium borohydride at 10 mM had no effect on 
HGPRTase activity; mean (± S.D.) values of 583 ± 75 
nmole /min. /ml red cells were obtained for a control 
series and of 583 
± 
78 nmole /min. /ml red cells when 
assayed in the presence of 10 mM sodium borohydride. 
Erythrocyte HGPRTase activities from the O - 2 
year old group were 611 
f 
81.9 nmole /min. /ml red 
cells (n = 8) and 104.3 ±4.5 nmole/h /mg protein 
(n = 3) . Mean (± S.D.) HGPRTase activities in the 
2 - 10 year age range were 587.3 72.6 nmole /min. /ml 
red cells (n = 11) and 111.0 7.5 nmole/h /mg protein 
(n = 4) . 
Erythrocyte APRTase, from the same group of 
patients in the 0 -2 year group, were 188.6 
± 
50.6 
nmole /min. /ml red cells (n = 10) and 37.0 } 9.0 nmole/ 
h /mg protein. In the 2 - 10 year age group mean 
(- 
f 
S.D.) values obtained were 194.6 - 
} 51.3 nmole /min. /ml 
red cells (n = 11) and 36.5 
± 
5.3 nmole/h/mg protein 
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(n = 4) . 
The presence of 5 pM testosterone had no 
significant effect on erythrocyte HGPRTase activity. 
A control series of assays gave mean (± S.D.) 
values of 11.59 ± 4.19 percentage transformation 
of substrate compared with 11.17 
± 
5.65 (n = 11) 
percentage transformation in the presence of 5 rM 
testosterone. No significant effect was found in 
the presence of 10 IuM testosterone, control mean 
values of 11.87 
± 
9.25 per cent transformation of 
substrate compared with 10.79 
± 
9.0 (n = 14) in 
the presence of 10 pM testosterone. 
Nickel at 2.5 mM, an inexpensive and powerful 
inhibitor of 5'- nucleotidase, was found also to 
strongly inhibit HGPRTase. In a series of controls 
a mean (± S.D.) value of 9.8 -} 5.8 per cent 
transformation of substrate was obtained, and when 
assayed in the presence of 2.5 mM nickel mean values 
+ + 
(- S.D.) of 3.4 - 1.8 (n = 10) p er cent transformation 
of substrate were obtained. 
The effects of adding 1.5 mM thymidine 
triphosphate to the assay medium were not significant. 
In a control series a mean (- S.D.) value of HGPRTase 
activity of 10.33 -r 8.54 per cent transformation of 
substrate was obtained while in the presence of 1.5 mM 
TABLE VI 
EFFECTS OF LITHIUM IONS ON HGPRTase ACTIVITY 
PERCENTAGE TRANSFORMATION OF SUBSTRATE 







EFFECTS OF 4, 6, 8, AND 10 mM LITHIUM 
IONS ON HGPRTase ACTIVITY 
Percentage Transformation of Substrate 
Control 2 mM Li} 4 mM Li} 6 mM Li} 8 mM Li+ 10 mM Lip 
1.54 1.61 1.45 2.02 1.6 1.41 
2.06 1.23 2.02 2.84 2.1 1.74 
10.4 10.6 11.3 12.9 10.3 9.7 
10.2 10.4 10.4 10.6 9.9 10.3 
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thymidine triphosphate a mean (± S.D.) of 10.45 
± 
8.63 (n = 10) per cent transformation of 
substrate was obtained. 
Assays of 5'- nucleotidase activity on 
erythrocyte lysates prepared as described in 
section 2.2a showed activities of less than 0.5 
nmole/h /mg protein. 
Lithium ions had no effect on HGPRTase 
activity at 2 mM but slight inhibition may be 
evident at higher concentrations (Tables VI and VII) . 
3.1c Discussion 
Validity of assay method After initial 
difficulties in the preparation of purine substrates, 
mainly due to the low solubility of purine at pH 7.4, 
the present assay method proved to be a practical 
method of determining PRTase activity. 
The mass of substrate purine transformed under 
the conditions of assay was linear with time of 
incubation up to sixteen minutes (Fig. 9) or twenty - 
eight per cent transformation of available substrate 
base. When larger percentages of transformation of 
substrate were found, deviations from linearity were 
noted, probably due to the contribution from the 
back reaction. 
AMP + PPi < Adenine + PRPP +2 
63 . 
Similar results were obtained for 
increasing enzyme volume and increasing time 
of incubation for erythrocyte APRTase. 
The coefficient of variation of the assay 
method for HGPRTase was determined from a series 
of fifty duplicate assays according to the method 
of Henry and Dryer (1963). A coefficient of 
variation of 9.6% was obtained for a mean of 95.3 
nmole/h /mg protein. 
Sodium borohydride at 10 mM had no activating 
effect on HGPRTase and was not subsequently added 
to the assay medium. 
HGPRTase is inhibited by the sulphydryl 
binder p- chloromercuribenzoate(Krenitsky and 
Papaioannou, 1969) and therefore it would appear 
that an -SH group is involved at the active centre. 
However, these results in conjunction with in vivo 
stability studies (section 3.4) would indicate that 
this -SH group is relatively stable to oxidation. 
Erythrocyte PRTase activities Erythrocyte HG 
and APRTase activities from a hospital population 
were determined in bloods obtained from the 
Haematology Department, Royal Hospital for Sick 
Children. The results obtained are similar to those 
of Cartier and Hamet (1968) and of Kelley et al. 
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(1967a). The latter group of workers used a 
different assay method. 
The values obtained by Cartier and Hamet 
(1968) and by Kelley et al. (1967) are compared 
in Table VIII with the values obtained in this 
study. 
Effects of potential modifiers of HGPRTase 
activity Testosterone at 5 and 10 IuM had no 
significant effect on HGPRTase activity 0.4< P <0.5. 
Recent work by Oliver (1972) has, however, 
demonstrated that steroid hormones do effect 
nucleotide biosynthesis. Oestradiol -17 -E3 was 
shown to activate ribose -5- phosphate pyrophospho- 
kinase (EC 2.7.6.1) leading to an increase in PRPP 
concentrations and hence an increase in both de novo 
and salvage nucleotide synthesis. Oestradiol has 
also been shown to increase the uptake of purines 
by intact erythrocytes by Christensen and Jones 
(1961). Further studies on the effects of steroid 
hormones on tissue nucleotide synthesis are indicated. 
5'- Nucleotidase inhibitors Nickel ions at 
2.5 mM were effective inhibitors of 5'- nucleotidase, 
but were also strong inhibitors of HGPRTase P>- 0.001 

































































































































































































































































































































































































































































































































































































































































Thymidine triphosphate has been shown to 
be a powerful inhibitor of 5'- nucleotidase by 
Murray and Friedrichs (1969) and no inhibitory 
or activating effects were detected on HGPRTase 
0.7< P <0.8. Thymidine triphosphate was 
therefore added to the PRTase assay medium to a 
final concentration of 1.5 mM when tissue PRTase 
activities were determined. Tissue homogenates, 
other than erythrocyte lysates, have high 
5'- nucleotidase activity, some of which is 
solubilised during homogenisation with consequent 
hydrolysis of the PRTase reaction products. 
Lithium therapy and The 
urinary excretion of urate as a consequence of 
lithium carbonate therapy of manic depressive illness 
are obtained by maintaining plasma lithium levels 
of 2 mM. Using erythrocyte HGPRTase as a model for 
tissue HGPRTase, lithium ions at 2 mM had no effect 
on HGPRTase activity 0.6<P<0.7. 
Slight inhibition was observed at higher lithium 
concentrations, and the possibility of intracellular 
concentrations of 8 - 10 mM lithium with inhibition 
of HGPRTase may be worth further investigation. 
The evidence available would suggest, however, that 
intracellular lithium is lower than plasma lithium 
66. 
levels (Glen, personal communication, 1972). 
Role of the PRTases in the erythrocyte 
Erythrocytes have relatively high activities of 
the PRTases whose role in the nucleated precursors 
of the developing reticulocytes in the bone marrow 
is probably in the generation of nucleotides for 
RNA and DNA synthesis. The PRTase activities found 
in the bone marrow (section 3.4) were somewhat lower 
than those found in the mature erythrocyte, but 
this may be due to sampling difficulties with bone 
marrow. 
The half -lives of HG and APRTase in erythrocytes 
have been determined by Rubin et al. (1969), and a 
t2 of 82 days for HGPRTase and t2 of 34 days for 
APRTase have been found. APRTase from erythrocytes 
from Lesch -Nyhan patients had a try of 86 days, the 
increased stability probably being a result of 
stabilisation of the APRTase protein by PRPP. 
The role of the PRTases in the mature erythrocyte 
with no RNA or DNA metabolism is discussed more 
fully in section 3.7. 
3.2 CLINICAL STUDIES 
3.2a Introduction 
During the course of this work some patients 
admitted to the Royal Hospital for Sick 
Children were 
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investigated. Children who had signs and 
symptoms resembling those found in the Lesch- 
Nyhan syndrome were investigated by determining 
their erythrocyte HGPRTase and APRTase. 
The patient I.I. was referred by Dr D. 
Eccleston, Royal Edinburgh Hospital and the 
patients K.J. and E.J. by Dr D. Patrick, Great 
Ormond Street Hospital, London. 
A short summary of the case notes is presented, 
along with the PRTase activities and other relevant 
data. 
3.2b Results 
Patient A.L. Male 2.5 years admission. 
This child presented with recurrent haematuria, 
and after surgery was found to have a large oxalate/ 
urate bladder calculus. At the time of admission 
serum urate levels were 9.2 mg /100 ml, and urinary 
urate 191 mg /100 ml. Blood electrolyte and calcium 
levels, and renal function tests were normal. A.L. 
then developed a urinary tract infection, and serum 
urate levels which had fallen to 4.6 mg /100 ml 
began to rise and reached 8.0 mg /100 ml. Erythrocyte 
HG and APRTase determined at this time were, 
HGPRTase 575 nmole /min /mlerythrocytes and APRTase, 
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150 nmole /min /ml erythrocytes. 
Erythrocyte PRTase activity was determined 
one year later and values of 640 nmole /min /ml 
erythrocytes for HGPRTase, and 231 nmole /min /ml 
erythrocytes for APRTase were obtained. These 
values are normal (section 3.1). 
Patient J.S. Male aged 5 years on admission. 
This patient presented as a markedly ataxic child 
with choreoarthetoid movements of limbs and a 
coarse bilateral tremor. J.S. exhibited hyperactive 
behaviour and self -mutilation by head banging and 
arm biting. The E.E.G. showed slight generalised 
abnormalities. Haematological reports showed a 
marked anaemia of undetermined origin. 
Erythrocyte PRTase activity was determined and 
HGPRTase activity was 621 nmole /min /ml erythrocytes 
and APRTase 217 nmole /min /ml erythrocytes. These 
values are normal (section 3.1). 
Patient S.B. Male aged 6 years on admission. 
Patient S.B. was slightly retarded in both motor 
and intellectual development. He was referred due 
to his self -mutilating behaviour, biting the flesh 
from his hands and arms. His general health was 
good. His teeth were removed to prevent further 
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damage to himself, and erythrocyte HGPRTase 
activity determined. HGPRTase activity was 
588 nmole /min /ml erythrocytes; this is normal 
(section 3.1) . 
Patient I.I. Female aged 65 years 
Patient I.I. was admitted to the Royal Edinburgh 
Hospital with manic depressive illness. She had 
a serum urate level of 11.3 mg% which was 
subsequently found to be due to psoriasis. There 
was family history of anaemia of undetermined type. 
Erythrocyte PRTases were determined, and 
HGPRTase activity of 500 nmole /min /ml erythrocytes 
and APRTase activity of 164 nmole /min /ml erythrocytes 
were obtained. These values are at the lower end 
of the normal range (section 3.1). 
Patients E.J. and K.J. Females aged 1 year 
and 2.5 years on admission. These sisters were 
admitted to the Great Ormond Street Hospital, London 
and were mentally retarded. The elder sister, K.J., 
had mutilated her lower lip by biting and both 
children exhibited marked choreoarthetoid movements. 
K.J. is shown in Fig. 10. 





Unusual posture adopted by 
patient K.J. 
TABLE IX 
THERMAL DENATURATION RATE CONSTANTS FOR APRTase AT 56 °C 
FROM CONTROLS AND PATIENTS E.J. AND K.J. 
Subjects No. of 
Determinations 
Denaturation Rate Constant 







(4) 0.182+ 0.009 
0.30 
0.4I 




and the HGPRTase activity was found to be 
580 and 630 nmole /min /ml erythrocytes for K.J. 
and E.J. respectively. APRTase activity was 
198 and 195 nmole /min /ml erythrocytes for K.J. 
and E.J. respectively. In view of the low APRTase 
activity this enzyme was further investigated. 
The thermal denaturation rate constants 
for APRTase from erythrocytes and cultured 
fibroblasts at 56oC were determined as described 
in section 2.8, and are presented in Table IX. 
The erythrocyte APRTase from these patients 
was more heat labile than control APRTase. 
In a further attempt to determine if an 
abnormal APRTase protein was present, the electro- 
phoretic and kinetic properties of the erythrocyte 
APRTase were investigated. The electrophoretic 
properties and apparent Km for adenine for both E.J. 
and K.J. were similar to those obtained for 
controls determined at the same time. 
3.2c Discussion 
Most of the patients studied had neurological 
symptoms resembling those found in Lesch -Nyhan 
children. No abnormal HGPRTase activity was 
detected; this provides further evidence that a 
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large number of brain disorders can result in 
similar signs and symptoms. 
The studies on APRTase from the children 
K.J. and E.J. would suggest a normal APRTase in 
spite of the apparently lower denaturation rate 
constant detected for the enzyme in erythrocytes. 
This destabilisation could be the result of high 
intracellular oxypurine or reduced PRPP concentrations 
(Rubin and Earl Balis, 1972). 
The low erythrocyte APRTase activity recorded 
for patient A.L. when his serum urate was 9.2mg% 
is unlikely to have been a result of an error in 
the laboratory as controls run at the same time 
gave normal results. Normal erythrocyte APRTase 
activities were recorded for this child when his 
serum urate was normal one year later. The 
possible significance of this finding is being 
investigated. However, the results may be due 
to the greater lability of APRTase compared to 
HGPRTase (section 3.4). 
3.3 TISSUE 5'- NUCLEOTIDASE ACTIVITY 
3.3a. Introduction 
The results of enzyme assays carried out 
using tissue homogenates as an enzyme source can 
often be invalidated by the presence of any one of 
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several factors. These include the presence 
of inhibitors or activators of the enzyme 
studied, which may act by mass action or by 
allosteric mechanisms. 
A tissue homogenate containing high levels 
of pyrophosphate would be inhibitory in the PRTase 
reactions, due to product inhibition. 
Base + PRPP > Nucleotide + PPi 
When a reaction product is being measured 
to determine enzyme activity this compound may be 
further metabolised by other enzymes present in 
the tissue homogenate. This situation occurs 
with the products of the PRTase reactions; AMP, 
IMP, and GMP are substrates for 5'- nucleotidase 
EC 3.1.3.5 (5'Nase) which hydrolyses these 
nucleotides to the corresponding nucleosides. 
Assays of PRTase activity in tissue homogenates 
which depend on the measurement of the nucleotide 
product will therefore underestimate PRTase 
activity. 
Assays of PRTase activity by determining the 
radioactivity in both the nucleotide and 
nucleoside corresponding to the substrate base 
used are a justifiable method of overcoming the 
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effects of 5'- nucleotidase. However, such 
methods will tend to overestimate PRTase activity. 
This is due to the formation of nucleosides from 
the free base in the presence of ribose -l- 
phosphate by the enzyme nucleoside: orthophosphate 
ribosyltransferase activity EC 2.4.2.a (Sweetman 
et al., 1972) . 
Hypoxanthine or Guanine + Ribose -1 -P - Nucleoside + Pi 
This limitation does not apply in mammalian 
tissues in the assay of APRTase, as no enzyme has 
been detected capable of the direct formation of 
adenosine from adenine (Huennekens et al., 1956). 
The results presented in this section show 
the 5'Nase activities in some human tissues, and 
the efficiency of 1.5 mM TTP as an inhibitor of 
5'Nase. 
The effects of 1.5 mM TTP on the APRTase and 
HGPRTase activities measured as described in 
section 2.3 are presented. 
3.3b. Results 
5'- Nucleotidase activity was detected in the 
supernatants of tissue homogenates from all the 
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tissues studied. Results are presented in 
Table X of 5'- nucleotidase activities in 
nmole/h /mg protein with GMP as a substrate 
assayed as described in section 2.6. 
In foetal liver and cerebral cortex, 
5'- nucleotidase levels are low compared to the 
adult tissue, much higher activity was detected 
with AMP as a substrate. 
Highest activities were found in central 
nervous system and in liver. Very much lower 
activities were detected in adult kidney and bone 
marrow. 
No 5'- nucleotidase activity was detected in 
erythrocyte lysates. 
The inhibition of 5'- nucleotidase by 
1.5 mM thymidine triphosphate for various tissues 
is shown in Table Xl. The percentage inhibition 
ranges between 19.2% for foetal liver and 100% 
inhibition in adult cerebral cortex. Higher 
percentage inhibition was obtained when larger 
amounts of substrate were transformed (Tables 
XII and XIII). 
The effects of 1.5 mM thymidine triphosphate 
in the PRTase assay system are shown in Table XII 
for HGPRTase and Table XIII for APRTase. 
TABLE X 
DISTRIBUTION OF 5'- NUCLEOTIDASE ACTIVITY IN HUMAN 
TISSUES USING GMP AS SUBSTRATE 
Tissue Age 
5'Nase Activity 
nmole/h /mg Protein 




foetus 81.5 [107] 
Basal nuclei 380 
Cerebral cortex 
Grey matter O'S 940 
Cerebral cortex years 
White matter 96 
Liver 292 
Cerebral cortex 
Grey matter 2.0 354 
Cerebral cortex years 
White matter 139 
Thalamus 260 
Liver 40 
Basal nuclei 287 
Testis 149 
Kidney 33 
Bone marrow Adult 16.4 
Medulla 358 
Cerebral cortex 252 
Grey matter 144 
Cerebral cortex 192 
White matter 
The figures in parenthesis represent the 
5'nucleotidase activity with AMP as a substrate 
TABLE XI 























Grey matter 100 
Cerebral cortex 
White matter 100 
The figures in parenthesis represent 
percentage inhibition 5 °- nucleotidase 
with AMP as a substrate 
TABLE XII 
PERCENTAGE INCREASE IN MEASURED HGPRTase ACTIVITY ASSAYED 
IN THE PRESENCE OF 1.5 mM THYMIDINE TRIPHOSPHATE 
Tissue Age Percentage 
Increase 
Thalamus 89 
Cerebral cortex 0.002 




0.45 38 Cerebral cortex 
White matter year 430 
Kidney 23 
Basal nuclei 180 
Cerebral cortex 
0.5 Grey matter 
year 31 
Cerebral cortex 
White matter 0 
Cerebral cortex 
Grey matter 1.5 440 
Basal nuclei year 380 
Liver 29 
Liver 6.0 150 
Thalamus year 335 
Liver 190 
Cerebral cortex 
Adult Grey matter 2 
Thalamus 68 
TABLE XIII 
PERCENTAGE INCREASE IN MEASURED APRTase ACTIVITY ASSAYED 









Not detected in 














Not detected in 
absence of TTP 
85 
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Significant increases in HGPRTase activity 
were observed after inhibiting 5'- nucleotidase 
with 1.5 mM thymidine triphosphate. These 
increases in detected HGPRTase activity were 
particularly marked in the tissues of the 
central nervous system and in liver, increases 
of up to 440% being noted. Percentage 
increases in activity in tissues other than 
central nervous tissue and liver were generally 
much lower, 23% increase in kidney HGPRTase and 
25% with adrenal HGPRTase. The small increases 
in activity of O and 2% may have been due to 
more prolonged storage of these tissues. 
The percentage increase in measured APRTase 
activity (Table XIII) was also high in nervous 
tissue and liver although a value of only 15.5% 
was obtained for adult liver. As the levels 
of APRTase are low in the central nervous system 
(see section 3.4), theoretically infinite 
increases in activity were obtained in the 
thalamus (adult) and cerebral cortex grey matter 
(0.02 yr.) when no APRTase activity was detected 
in the absence of thymidine triphosphate. 
Similar results were obtained with rat tissues. 
Nickel ions at 5 mM totally inhibited 
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5'- nucleotidase, obtained from all tissues 
examined. Nickel ions were also powerful 
inhibitors of HGPRTase (section 3.1) and were 
therefore not further investigated. 
3.3c. Discussion 
5'- Nucleotidase, first described by Reis 
(1934), hydrolyses the phosphate group of the 
fifth carbon atom of ribose nucleotides. 
A wide variety of assay methods has been 
reported (see Bodansky and Schwartz, 1968), and 
difficulties in interpretation of results include 
the contribution to hydrolysis from non -specific 
acid and alkaline phosphatases EC 3.1.3.1 and 
EC 3.1.3.2. 5'- Nucleotidase was reported to be 
present in all human tissues except the intestinal 
mucosa (Reis, 1951; Planteydt and Willighagen, 
1960) while Pearse and Reis (1952) reported that 
the tissue distribution of 5'- nucleotidase was 
different from that of the non -specific phosphatases. 
Comparisons of tissue 5'- nucleotidase 
activities obtained in this study with other 
reported values are difficult due to the wide 
variety of methods of assay used and to the report 
by Bjork (1964) that the nature of the buffer 
anion affects activity. 
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The available evidence would suggest that 
in this work true 5'- nucleotidase activity is 
being measured because magnesium ions activate 
5'- nucleotidase at pH 7.4 (Belfield and Goldberg, 
1969) and at the pH used in the assay the non- 
specific phosphomonoesterases show only 5% of 
their maximal activity at optimal pH (King, 1965) 
5'- nucleotidase activity has therefore been 
measured under conditions almost identical to those 
of the PRTase activities. This enables an 
evaluation of the contribution of 5'- nucleotidase 
breakdown of the PRTase reaction products in 
tissue homogenates to be made. 
In this work, high 5'- nucleotidase 
activities were found in the central nervous 
tissues (Table X), higher values being found in 
the white matter than in the grey matter. Foetal 
5'- nucleotidase showed a higher catalytic activity 
with AMP as substrate than with GMP (Table X) . 
This may indicate the presence of separate enzymes 
in the foetus for the hydrolysis of AMP and GMP - 
as is found in chick brains (Manzoli, Ipata and 
Wegelin, 1971), but further studies on this would 
be required to arrive at a positive conclusion. 
Little is known about the physiological role 
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of 5'- nucleotidase, but as AMP is important 
in the regulation of at least three important 
enzymes in the Embden Meyerhoff pathway and 
the tricarboxylic acid cycle (Atkinson, 1966) 
it is possible that amongst other functions, 
5'- nucleotidase, by lowering AMP levels, influences 
the activities of these enzymes. The role of 
5'- nucleotidase in growth has been studied by 
Panda et al., 1962 who found significant increases 
in 5'- nucleotidase after injections of growth 
hormone. This work in conjunction with the 
finding of elevated serum 5'- nucleotidase in a 
wide variety of neoplastic diseases by Kowlessar 
et al., 1961 strongly suggests that 5'- nucleotidase 
is important in the turnover of nucleotides during 
periods of rapid growth. 
The inhibition of 5'- nucleotidase by thymidine 
triphosphate was reported by Murray and Friedrichs 
(1969), and this study shows effective inhibition 
of 5'- nucleotidase particularly in tissues with 
a high specific activity. 
Assays of HG and APRTase carried out in the 
absence and presence of 1.5 mM thymidine triphosphate 
showed significant increases in the PRTase activity 
detected. This was shown by initial studies on red 
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cell lysates not to be due to any stimulation 
of the PRTase by TTP, or via any increase in 
PRPP levels. These lysates, with no detectable 
5'- nucleotidase activity, showed no increase in 
PRTase activity (section 3.1). 
As thymidine triphosphate was shown to 
inhibit 5'- nucleotidase and to increase the values 
of PRTase activity it was subsequently added to 
the assay system for the PRTases at a final 
concentration of 1.5 mM. As 5'- nucleotidase 
inhibition is unlikely to be total at all times, 
the PRTase activities reported in section 3.4 may 
still represent slight underestimations of true 
tissue PRTase activity. 
3.4 HUMAN TISSUE PURINE PHOSPHORIBOSYLTRANSFERASE 
ACTIVITIES 
3.4a. Introduction 
Previous estimates of tissue PRTase activities 
are probably low due to the breakdown of the product 
nucleotide AMP, IMP or GMP by the action of 
5'- nucleotidase. 
5'- Nucleotidase, EC 3.1.3.5, can be inhibited 
by thymidine triphosphate, and the PRTase activities 
determined in this work were made using a new assay 
method incorporating 1.5 mM thymidine triphosphate 
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to inhibit the destruction of the assay product. 
Purine phosphoribosyltransferase activities 
have been determined in adult human tissues by 
Rosenbloom et al. (1967), and in tissues from the 
Rhesus monkey by Krenitsky (1969). Murray (1966) 
who determined PRTase activities in mouse and rat 
tissues, and in Erlich ascites tumour cells, observed 
changes in the activity of the PRTases in rat liver 
extracts following partial hepatectomy. 
Boyle et al. (1970) determined the activity 
and stability of PRTases in tissues from a human 
foetus, and Epstein (1970) studied the early develop- 
mental increases in PRTase activity in pre and post - 
implantation mouse embryos. 
There is an absence of detailed work on the 
distribution of the PRTases in human tissues, and 
no information on the changes in the activities of 
these enzymes which occur between foetal and adult life. 
The present work was carried out in order to 
provide this information. 
Knowledge of changes in PRTase activity with 
growth and development, and the relative importance 
of HGPRTase and APRTase between tissues, may reveal 
some role for these enzymes in growth and development 
and may help to explain the delayed onset of the 
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neurological symptoms in children with the 
Lesch -Nyhan syndrome (Nyhan, 1968). The 
distribution of activities between different 
tissues may help to clarify the role of these 
salvage pathways in the purine metabolism of the 
whole animal. 
The human tissues were obtained at necropsy, 
generally within twenty -four hours of death, by 
Dr J.M. Anderson, Department of Paediatric Pathology, 
the Royal Hospital for Sick Children. 
As tissues were generally obtained for study 
of the PRTase activity between twelve and twenty -four 
hours after death, the in vivo stability of HG and 
APRTase was determined in tissues removed surgically 
and stored at 4oC. 
As the PRTases are synthesising nucleotides 
for RNA and DNA biosynthesis which occurs in the 
nuclear compartment of the cell, a study was carried 
out on the cellular localisation of HGPRTase. 
In an attempt to determine the specific cell 
type with high HGPRTase activity in the testis, 
autoradiographic investigations were carried out. 
In view of the importance of cells from tissue 
culture in clinical diagnosis and in experimental 
work, the PRTase activities from a number of human 
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cell lines were determined. 
Results are presented of HGPRTase activities 
in a series of human tissue culture cell lines 
obtained from Dr P. Gormley, M.R.C. Clinical and 
Population Cytogenetics Research Unit, and from 
Dr A.D. Bain, Department of Paediatric Pathology, 
the Royal Hospital for Sick Children. 
3.4b. Results 
Stability of the PRTases The stabilities of 
the PRTases in surgically removed tissue obtained 
from Mr F.H. Robarts and Mr W.H. Bisset, the Royal 
Hospital for Sick Children, are presented in Fig. 11 
(liver) , Fig. 12 (ileum) and Fig. 13 (appendix) . 
The tissues were stored at 4oC and HG and APRTase 
activities determined immediately after surgery, at 
twenty -four and at forty -eight hours subsequently. 
HGPRTase is slightly more stable than APRTase in 
the tissues studied. A half -life of about fifty 
hours was calculated for HGPRTase and of thirty for 
APRTase when stored at 4oC. Slight variation in 
half -lives was observed between the tissues studied. 
The enzymes were less stable in liver than in ileum. 
From the results obtained there would be a loss of 
about 15% activity on storage for 24 hours as in many 
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Foetal tissue PRTase activities Foetal 
tissue PRTase activities were determined on 
foetuses made available by Dr F. Cockburn, Simpson 
Memorial Maternity Pavilion, Edinburgh. Foetal 
HGPRTase activities are presented in Table XIV 
and APRTase activities in Table XV. Means and 
standard errors of the mean are presented where 
appropriate. 
HG and APRTase activities are presented 
throughout this section in units of nmole of 
hypoxanthine or adenine transformed per hour per 
milligram of protein. 
Foetal HGPRTase activity is lower than adult 
tissue levels, however, the relationship of 
activities between the tissues was generally similar 
to that found in adults. One exception to this 
was found in ovarian tissue where activity was not 
detected in the adult. 
Foetal HGPRTase activity was low in liver, 
35.3 
± 
S.E.M. 6.84, cerebral cortex, 47.6 
± 
S.E.M. 
16.6, and in basal nucleii, 53 } S.E.M. 28.6, when 
compared to adult levels. Higher than adult 
HGPRTase activities were found in the cerebellum, 
150 and high activity was detected in the foetal 
ovary. Foetal testis had a high HGPRTase activity, 
TABLE XIV 





nmole/h /mg Protein 
8 44 
12 21 




Kidney 12 19 
Spleen 12 63 
Lower trunk 12 39 
Upper trunk 12 28.2 
8 143 
Whole brain 12 27.7 
14 73 
12 30 
Cerebral cortex 21 81 
22 32 
Cerebellum 21 150 
12 0 
Basal nuclei 21 98 
22 63 
Ovary 22 130 
Testis 21 203 
Placenta 12 23 
TABLE XV 











Lower trunk 12 72 
Upper trunk 12 41 
8 52 
Whole brain 12 64 
14 61 
Cerebral cortex 22 42 
Basal nuclei 22 27 
Ovary 22 0 
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203, but considerably lower than adult values. 
Placental tissue had low activity, 23, 
although this organ is metabolically very active 
in transport of nutrients to the foetus. 
Foetal APRTase activity in liver, 32.5 
± 
S.E.M. 
1.1 was lower than that found in adult liver, 
but foetal central nervous system had considerably 
higher APRTase activities, 59 S.E.M. 3.6 than 
that found in the adult. No APRTase activity was 
found in foetal ovary. 
PRTase activities in tissues from children aged 
O - 2 years The HG and APRTase activities in 
tissues from children aged O - 2 years are 
presented in Table XVI and Table XVII. 
Highest HGPRTase activities were found in 
the testis and the central nervous system. 
Considerably higher HGPRTase activities were 
detected in the cortical grey matter than in the 
cortical white matter. The basal nuclei had the 
highest activity found. Lower levels of activity 
were detected in the medulla, while the cerebellum 
had very low levels of activity. This contrasts 
with the high HGPRTase activity in the foetal 
cerebellum (Table XIV) . 
Low levels of HGPRTase activity were detected 
TABLE XVI 
HYPDXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY 
IN TISSUES FROM CHILDREN AGED 0 - 2 YEARS 
Tissue 
HGPRTase Activity 
Mean - S.E.M. 
nmole/h /mg Protein 
No . of 
Determinations 
Liver 39.8 ± 7.0 11 
Kidney 47.2 t15.9 7 
Adrenals 21.0 ±7.2 4 
Thymus 53.2 ±13.9 5 
Pancreas 19.0 -9.4 4 
Skeletal muscle 12.8 ±3.2 5 
Cardiac muscle 37.8 t9.3 5 
Bone marrow 42.3 ±11.9 3 
Testis 126.2 ±47.4 4 
Cerebral cortex 128.4 -42.1 9 
Grey matter 
Cerebral cortex 68.2 -15.9 8 
White matter 
Basal nuclei 157.3 -22.0 3 
Thalamus 81.8 -19.0 8 
Internal capsule 52.7 -18.8 3 
Medulla 75.7 -18.0 6 
Cerebellum ± 29.3 4 .3 3 
TABLE XVII 
ADENINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY IN 
TISSUES FROM CHILDREN AGED O - 2 YEARS 
Tissue 
APRTase Activity 
+ Mean - S.E.M. 
nmole/h /mg Protein 
No. of 
Determinations 
Liver 88.7 ±38.6 6 
Kidney 42.0 -7.0 3 
Thymus 95.6 -38.4 4 
Skeletal muscle 69.2 -50.7 2 
Cardiac muscle 33.2 ±16.7 2 
Testis 52.5 -24.4 4 
Cerebral cortex 12.7 ±5.5 4 
Grey matter 
Cerebral cortex 21.0 -7.7 4 
White matter 
Basal nuclei 5.7 -2.2 3 
Thalamus 12.3 ±6.8 4 
Medulla 19.0 -2.8 3 
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in the liver, adrenals, kidney, thymus, bone 
marrow and muscle. Cardiac muscle had higher 
HGPRTase activity than did skeletal muscle. 
APRTase activities in tissues from the O - 2 
year age group (Table XVII) were highest in liver 
and thymus. 
Skeletal muscle had higher APRTase activity 
than cardiac muscle. Kidney and testis had low 
APRTase activity. Central nervous tissues had 
low APRTase activity, often not detectable in the 
absence of thymidine triphosphate. 
PRTase activities in tissues from children aged 
4 - 8 years The HG and APRTase activities in 
tissues from children aged 4 - 8 years are shown 
in Table XVIII and Table XIX. Many of the children 
in this study had been on cytotoxic drugs prior to 
death. 
Liver HGPRTase activity is higher than in the 
O - 2 age group, 78 S.E.M. 26.8 as is the 
cortical grey matter, 170.7 
± 
S.E.M. 34.6, medulla, 
157 and thalamus, 136. 
Liver APRTase, 122, is increased greatly 
compared to the O - 2 age group, while central 
nervous system APRTase shows only slight increases 
TABLE XVIII 
HYPDXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY 





nmole/h /mg Protein 
6 25 
Liver 7 103 
8 108 
Appendix 4 50 
Ileum 4 89 
Ovary 7 0 
Testis 8 93 
6 196 
Cerebral cortex 7 95 
7 138 
Grey matter 8 254 
Occipital grey 7 105 
Occipital white 7 0 
Thalamus 6 122 
Thalamus 7 145 
Medulla 6 157 
TABLE XIX 
ADENINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY IN TISSUES 





nmole/h /mg Protein 
Liver 6 122 
Skeletal muscle 6 53 
Appendix 4 121 
Ileum 4 107 
Cerebral cortex 6 28 
Grey matter 
Cerebral cortex 6 35 
White matter 
Thalamus 6 24 
Medulla 6 44 
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in activity. 
PRTase activities in tissues from adults aged 
60 - 80 years Adult tissue HG and APRTase 
activities are presented in Table XX and Table XXI, 
and reproductive tissues in Table XXII. 
Liver HGPRTase activity is similar to that 
found in the 4 - 8 year age group, while cortical 
grey matter shows a higher activity than that found 
in the 4 - 8 year age group. Thalamic and medullary 
HGPRTase are of similar levels. Testicular HGPRTase 
is higher than that previously detected by a factor 
of at least three 
PRTase activities in reproductive tissues 
Reproductive tissues were studied in view of their 
rapid growth rate and close involvement with nucleic 
acid biosynthesis. 
HGPRTase activity was detected in the myometrium 
and amnion membrane; activities were not high relative 
to other tissues (Table XXII). Antenatal diagnosis of 
the Lesch -Nyhan syndrome depends on the assay of 
HGPRTase from amniotic material. Low HGPRTase 
activity was detected in cells from amniotic fluid 
obtained by amniocentesis and very low activity was 
detected in the amniotic fluid. No HGPRTase activity 
TABLE XX 
HYPDXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY 




nmole/h /mg Protein 
No. of 
Determinations 
Liver 71.3 -10.9 6 
Kidney 42.3 -15.9 4 
Bone marrow 56.7 -11.9 3 
Testis 431.0 ±63.7 5 
Cerebral cortex 294.0 -57.8 4 
Grey matter 
Cerebral cortex 135.3 -25.0 4 
White matter 
Thalamus 192.7 -23.7 3 
Medulla 142.0 -5.0 4 
TABLE XXI 
ADENINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY IN TISSUES 
FROM ADULTS AGED 60 - 80 YEARS 
Tissue 
APRTase Activity 
Mean - S.E.M. 
nmole/h /mg Protein 
No. of 
Determinations 
Liver 165.2 -11.7 4 
Kidney 28.5 -12.0 3 
Bone marrow 16.4 -5.8 4 
Testis 59.7 -10.9 4 
Cerebral cortex 21.1 -10.7 4 
Grey matter 
Cerebral cortex 13.0 -5.5 4 
White matter 
Thalamus 19.4 -6.8 4 
Medulla ± 30.7 17.2 2 
TABLE XXII 
HYPDXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 
ACTIVITY IN MATERNAL REPRODUCTIVE TISSUES 
AND IN SEMINAL FLUID 
Tissue 
HGPRTase Activity 
nmole/h /mg Protein 
Endometrium 52 
Myometrium 29 
Amnion membrane 22 
Amniotic cells obtained 
by amniocentesis 
11 
Amniotic fluid 0.5 
Seminal fluid O 
Sperm 0 
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was detected in homogenised sperm or in seminal 
fluid. 
Pattern of developmental changes in tissue 
PRTase activity The developmental changes in 
tissue HGPRTase activity are summarised graphically 
in Fig. 14 and for APRTase in Fig. 16. 
The individual points for testis, cerebral 
cortex, and liver HGPRTase in foetus, children O - 2 
years of age and adults are shown in scattergrams in 
Fig. 15 
Subcellular distribution of HGPRTase activity 
The subcellular location was studied in 
testis and cerebral cortex where the great majority 
of activity was located in the soluble cytoplasmic 
fraction (Table XXIII) 
The cellular localisation of HGPRTase in testis 
Autoradiographic studies carried out on HGPRTase 
localisation in the testis of a child aged 1 year 
are shown in Fig. 17. 
The HGPRTase activity is localised around the 
periphery of the tubules and the cell type is 
therefore the germ cells or the sertoli cells or 
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Autoradiograph of transverse section 
of semeniferous tubule 
Fig. 18 
Autoradiograph of testicular 
capsule showing a transverse 
section of a small blood 
vessel 
TABLE XXIV 
HYPDXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY 
IN CULTURED HUMAN CELLS 
Cell Line 
HGPRTase Activity 
nmole/h /mg Protein 
Human lung fibroblasts 
H- 120 -16 19.5 
Fibroblasts: genotype XXX 3 
Embryonic lung fibroblasts 3 
Human amnion cell line 
transformed with virus SV40 
224/168 146 
Human amnion cell line 
derived with subsequent 
transformations from 224/168 
244 170 
Human amnion cell line derived 
from 244. Resistant to 
RZACivAkIthJ G and thioguanine 
at 50 dug /ml 2.6 
 
An autoradiograph of the testicular capsule is 
shown in Fig. 18. This Figure shows HGPRTase 
activity located around the walls of blood vessels. 
These findings suggest that the enzyme may be 
involved in the transport of hypoxanthine from the 
erythrocyte into tissues; an efficient process in 
rabbit testis (section 3.7). Blood vessels in the 
thyroid did not show such activity. 
HGPRTase activity in cultured human cells The 
HGPRTase activity in cell lines from cultured human 
tissues is shown in Table XXIV. 
Most tissues examined had low HGPRTase 
activities, but cells 224/168 transformed by a virus 
SV4O had high HGPRTase activity, which was increased 
in line 244 after further viral transformation. A 
cell line derived from amnion 244 and resistant to 
the anti -tumour agent 8- azaguanine had very low 
HGPRTase activity. This illustrates the role of 
HGPRTase in the drug activation steps converting many 
anti- tumour drugs into their active form. 
3.4c. Discussion 
Studies on human tissues obtained at necropsy 
are likely to give results for enzyme activities 
somewhat lower than those obtained from fresh tissue. 
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This is due to the delay between death and post- 
mortem. During this period, enzyme synthesis is 
no longer taking place and existing enzyme protein 
0. 
will be liable to destruction by acid hydrolyses 
released from lysosomes following tissue death 
(Slater, 1969). The cause of death may also affect 
the results obtained, for example, liver disease or 
cerebral oedema may be expected to affect the measured 
enzyme activities in liver and brain respectively. 
These limitations are unfortunately almost inevitable 
when studying human biochemistry, and should be 
considered when interpreting the results. However, 
from a number of necropsies show the same 
relative distribution of activities between tissues, 
and often show a close similarity in the individual 
figures. 
Studies on the stability of the PRTases in fresh, 
surgically removed tissues stored at 4 °c (Figs. 11, 
12 and 13) would suggest that both HG and APRTase are 
relatively stable in the tissues studied, with half - 
lives of approximately fifty hours and thirty hours 
respectively. This represents a loss of about 15% 
activity prior to assays being carried out on tissues 
obtained at necropsy twenty -four hours after death. 
These findings on tissues from children are 
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consistent with the work of Boyle et al. (1970) 
who determined the stability of the PRTases in 
foetal tissues. 
Both HGPRTase and APRTase activities were 
detected in all the human tissues studied with the 
exception of sperm and seminal fluid. The highest 
HGPRTase activities were detected in the testis and 
central nervous system at all ages studied. In 
contrast, APRTase activity was highest in brain in 
foetuses, highest in the thymus in children aged O - 2 
years, and was highest in the liver in children aged 
4 - 8 years and in adults. 
The changes in PRTase activities observed with 
growth and development were therefore a rise in 
HGPRTase activity in testis and central nervous 
system tissues, and a rise in hepatic APRTase activity. 
A slight fall in central nervous system tissue APRTase 
activity was observed. 
Tissues such as testis, thymus, and bone marrow 
probably have a high requirement for nucleotides for 
DNA synthesis as all of these tissues are 'exporting' 
cells to other parts of the organism. 
Central nervous system tissues have high RNA 
turnover rates (see Glassman, 1969), and will require 
a constant supply of nucleotides in the appropriate 
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5'- nucle4ide triphosphates form to sustain RNA 
synthesis. 
The nucleotide pools of these tissues can 
be replenished by de novo synthesis from PRPP and 
glutamine to generate IMP, or by the salvage 
pathways via the PRTase reactions to generate AMP, 
GMP, or IMP. 
As both brain and testis have high HGPRTase 
activities, it would seem likely that this salvage 
pathway is important in the maintenance of these 
tissues nucleotide pools. In addition, Howard et al. 
(1970) has reported that the brain has a low de novo 
synthetic capacity for purine nucleotides. 
In both testis and brain, nucleotides or their 
degradation products are not totally lost from the 
organ. In the testis, approximately twenty per cent 
of the sperm cells are reabsorbed (Amann, 1969) and 
the sperm DNA is available for degradation to 3' and 
5' AMP and GMP by DNases. The high activities of 
5'- nucleotidase and non -specific phosphatases in the 
male genital tract (Mann, 1964) may be involved in 
the breakdown of these 3' and 5'- nucleotides via 
adenosine and inosine to hypoxanthine and via guanosine 
to guanine. These free bases can then be 'salvaged' 
to reform 5'- nucleotides. Similarly, in the central 
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nervous system, messenger RNA after hydrolysis 
by RNase to 3' and 5' AMP and GMP can give rise 
to moieties which can be recycled intracellularly 
by HGPRTase to replenish the cell nucleotide pool. 
In contrast to brain and testis, the other 
two tissues which might be expected to have high 
nucleotide requirements, bone marrow and thymus, do 
not have high PRTase activity. Activities have 
not been determined in adult thymus due to sampling 
difficulties. A possible explanation is that in 
thymus and in bone marrow the bulk of the nucleotides 
is synthesised by the de novo pathway. 
It is of interest, however, that some children 
with the Lesch -Nyhan syndrome have megaloblastic 
anaemia which is improved by adenine therapy but 
unresponsive to vitamin B12 therapy (Ghadimi et al., 
1970; Van der Zee et al., 1970). This, and the work 
of Lajtha and Vane (1955) would suggest that the bone 
marrow can 'salvage' exogenous adenine; there are no 
studies on the salvage of hypoxanthine by the bone 
marrow. Another possible explanation for the low 
HGPRTase activities in bone marrow and thymus is that 
DNA synthesised in these tissues is exported from the 
organ intracellularly, and is therefore unavailable for 
recycling and salvage as probably occurs in brain and testis. 
93. 
Moderately high HGPRTase activity, 130, was 
detected in a foetal ovary of twenty -two weeks 
gestation, compared to the low activity, 27, found 
in the ovary of a four -month old child, while no 
HGPRTase activity was detected in an adult ovary. 
It may be relevant that meiosis is initiated in the 
foetal ovary and the period of rapid cell division 
in this organ is between the fifteenth and twentieth 
weeks of foetal life (Franchi, Mandl and Zuckerman, 
1962). This may be related to the high HGPRTase 
activity detected at this time. 
To summarise the main developmental changes in 
the PRTases: HGPRTase activity rises with development 
in the brain and in the testis, while APRTase activity 
rises with development in the liver but falls in the 
cerebral cortex and in all central nervous system 
tissues. 
If the rise in HGPRTase activity in the central 
nervous system tissues is related to functional 
changes, this would provide an explanation for the 
delayed onset of the neurological symptoms in children 
with the Lesch -Nyhan syndrome. 
Developmental aspects of enzymology are 
important in the care of the premature baby as these 
determine the vulnerability of the child to influences 
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which can cause irreversible damage. A study of 
developmental enzymology is a basis for the 
diagnosis of genetic disease from amniotic cell 
tissue culture. The enzymes involved in 
carbohydrate metabolism have been widely investigated 
during foetal and neonatal life. Some of these 
enzymes, for example, fructose,1, -6 diphosphatase, 
rise throughout foetal and neonatal life, while 
enzymes such as pyruvate carboxylase rise rapidly 
after birth at a time when it is required for 
gluconeogenesis (for a review see Walker, 1971). 
The enzymes of purine nucleotide metabolism 
have not been so widely studied, however a study by 
Manzoli, Ipata and Wegelin (1971) has been reported 
on these enzymes in chick embryo brain. Manzoli 
et al. (1971) found that 5'-nucleotidase reached 
maximal activity at about twelve to fifteen days foetal 
age and fell rapidly by twenty -one days at hatching. 
Different activities and a three day difference in 
maximal activity were found with AMP and GMP as 
substrates, and two separate enzymes were suggested 
(section 3.3c) . 
Ipata, Manzoli and Wegelin (1970) demonstrated 
the involvement of adenosine deaminase and inosine: 
orthophosphate ribosyltransferase in the purine salvage 
95. 
pathway, and that these enzymes increased 
rapidly after birth. Similarly, Manzoli et al. 
(1971) reported that guanine aminohydrolase and 
guanosine: orthophosphate ribosyltransferase rise 
rapidly after birth. 
These studies and the present work would 
suggest that the enzymes involved in the 
cY F 
and salvage /hypoxanthine and guanine 
recycling 
in the central 
nervous system become important functionally some 
time after birth and its metabolic role increases 
throughout childhood. 
Although a role for HGPRTase has been proposed, 
the possible role of APRTase remains unclear. Free 
adenine is found in the urine, but only at very low 
levels in tissue fluids (Fink and Adams, 1968). 
However, no enzymic mechanism is known for the 
formation of free adenine as adenosine is not a 
substrate for purine nucleoside phosphorylase. 
(Huennekens, Nurk and Gabrio, 1956). It is possible 
that free adenine could arise from AMP via APRTase. 
Although the equilibrium for APRTase greatly favours 
AMP formation, high concentrations of AMP and 
pyrophosphate such as those found when the cell is 
depleted of ATP could result in the formation of 
adenine, especially when the adenine formed is 
removed 
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by the secretion of urine. This would provide 
a role for APRTase as a shunt for lowering 
cellular AMP levels in conjunction with AMP 
aminohydrolase, EC 3.5.4.6. 
In this work, HGPRTase activity in tissue 
homogenates was determined using hypoxanthine as 
a substrate. Hypoxanthine has two advantages over 
guanine as a substrate; it is more soluble at 
pH 7.4, and, more importantly it is not metabolised - 
as is guanine - by guanine aminohydrolase EC 3.5.4.3, 
an enzyme present in many tissues and found at high 
levels in the central nervous system (Rosenbloom et al., 
1967) . Hypoxanthine is oxidised to xanthine by 
xanthine oxidase EC 1.2.3.2, but this enzyme is found 
only in the liver (Watts et ál., 1965) . 
It is perhaps significant that the 'salvage' 
pathway found in brain and in testis is HGPRTase; 
with hypoxanthine as a substrate this will result in 
the formation of IMP which can be converted into 
AMP and GMP as required, under the cross -over control 
of the energy requiring reactions of adenylosuccinate 
synthetase EC 6.3.4.4 and of IMP dehydrogenase 
EC 1.2.1.14 (see section 1.6) . 
The role of hypoxanthine as the principal 
substrate for HGPRTase in vivo is indicated by studies 
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on the purine metabolism of xanthinuric 
patients carried out by Bradford et al. (1968) 
and by Ayvazian and Skaup (1966). Bradford et al. 
(1968) showed that while only 6% of the 960 mg 
hypoxanthine pool was excreted daily, the bulk 
of the xanthine pool was excreted. Ayvazian 
and Skaup (1966) showed that adenine was 
metabolised to hypoxanthine, and only 1% of the 
label was excreted during the first day, whereas 
guanine which was metabolised to xanthine by guanine 
aminohydrolase EC 3.5.4.3, was 63% excreted during 
the first day of the study. 
With the exception of the liver, tissues 
do not contain appreciable xanthine oxidase 
activity EC 1.2.3.2 (Watts et al., 1965), while 
guanine aminohydrolase is widely distributed 
(Stem et al., 1952) and is present at high levels 
in the central nervous system (Rosenbloom et al., 
1967). In view of the excretion rate of purine 
bases, and the tissue distribution of the purine 
catabolising enzymes, it is suggested that hypoxanthine 
is probably the major substrate for HGPRTase in vivo. 
Studies on HGPRTase activity in cultured 
human 
cells (Table XXIV) are presented. Low levels 
of 
HGPRTase were found in 'normal' fibroblasts, 
but 
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fast growing cell lines derived from amnion 
by viral transformation exhibited high levels 
of activity. Subsequent transformation further 
increased HGPRTase activity. A fast growing cell 
line derived from the amnion line but resistant to 
50 pg /ml 8- azaguanine showed relatively low HGPRTase 
activity little different from that of two slow 
growing fibroblast lines with 'normal' levels of 
HGPRTase. An alteration of HGPRTase activity in 
regenerating rat liver has already been noted 
(Murray, 1966), and some correction of HGPRTase 
activities for rate and possibly phase of cellular 
growth may be necessary before attempting to make 
any comparisons. This is relevant to the problems 
of antenatal diagnosis from amnion cell tissue culture. 
The resistence of HGPRTase deficient cell 
lines to 8- azaguanine has been suggested by De Mars 
(1971) to be an effective method for diagnosing 
heterozygotes for HGPRTase deficiency. The active 
form of 8- azaguanine is 8- azaguanine nucleotide, 
and this is formed in vivo by HGPRTase; when 
HGPRTase is absent this drug is not activated and 
these cells become resistant to the normal growth 
inhibitory effects. 
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3.5 DEVELOPMENTAL CHANGES IN RAT TISSUE HYPDXANTHINE 
GUANINE PHOSPHORIBOSYLTRANSFERASE ACTIVITY 
3.5a. Introduction 
The data on developmental changes in human 
tissue HGPRTase activity (section 3.4) are 
incomplete because few people die in hospital 
between infancy and old age. As studies on 
human enzymology are often dependent on tissues 
obtained at necropsy, the period between two years 
and sixty -five years of age has not been adequately 
sampled. It is at some point during this period 
that the marked rises in testicular and central 
nervous system HGPRTase activities occur. 
The developmental changes in rat tissue 
HGPRTase activities were therefore studied in an 
attempt to determine if the testicular development 
of HGPRTase occurred largely at puberty and the 
increase in brain HGPRTase at an earlier age as 
might reasonably be predicted. It was 
hoped that 
the rat would provide a model for the 
changes 
expected to be seen in man. 
The rats used for this study 
were the P.V.G. 
strain developed by Glaxo Research 
Ltd. for 
nutritional studies; being a relatively 
slow growing 
strain they were especially suitable 
for developmental 
studies. The animals were obtained 
from the animal 
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house in the Department of Pharmacology, University 
of Edinburgh. The rats were fed ad libitum on 
oxoid breeding diet supplemented with brown bread 
and milk. They were weaned from their mothers 
at three weeks after birth, and reached reproductive 
age at about fourteen weeks. Groups of four 
siblings were killed by asphxyiation under nitrogen 
in order to minimise damage to the central nervous 
system. The following tissues were excised within 
twenty minutes of death: liver, testis, kidney, 
cerebral cortex, basal nuclei, and brain stem. The 
tissues were homogenised and the PRTase activity 
determined as described in section 2.3. 
The results are presented as the means and 
standard error of the means of HGPRTase activity 
in tissues from four rats from the same litter, 
generally two males and two females. It is possible 
that there were small sex differences, but a much 
larger sample would have been required to prove this 
and would not have been possible with litter mates. 
The growth curves for P.V,G. rats for total body weight 
and for combined testes weight is presented from 
data 





The means and standard errors of the means 
of tissue HGPRTase activity, from four rats in 
most instances, are presented in Table XXV. These 
results are presented graphically in Figs. 19 and 20. 
The activity of HGPRTase is seen to rise after 
birth in all tissues studied. The activity in 
liver rises after birth until four weeks of age and 
then falls until nine weeks. After nine weeks the 
activity increases to maximum level at fifteen 
weeks. Low activities were detected in sixty -five 
week rats. 
Both cerebral cortex and testis activities rise 
to a first maximum at two to three weeks, fall 
slightly between three and four weeks, then rise to 
maximal activity at fifteen weeks. Low activities 
of HGPRTase were detected in the cerebral cortex and 
testis at sixty -five weeks. 
The kidney HGPRTase activity also increased 
after birth until two weeks, fell slightly and had 
not greatly increased when determined at eighteen 
weeks. 
HGPRTase activity in the basal nuclei was 
constant between the second and fifth week after 
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GROWTH CURVES FOR TOTAL BODY WEIGHT (g) AND TESTIS WEIGHT (mg) FOR PVG RATS 
87 
Fig. 21 
From data obtained from Dr H.E.H. Jones, Glaxo Research 
Ltd. 
p - Total body weight 
O - Testes weight 
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and had returned to basal levels by the eighteenth 
week. 
The brain stem differed from all the other 
tissues studied, in that a slight fall in activity 
was observed between birth and the first week. 
This may, however, be an artefact of the small 
sample size. This tissue showed peaks of activity 
at the second, seventh and fifteenth weeks. 
Some changes in APRTase activities are shown 
in Table XXVI. Falls in APRTase activity parallel 
with those in HGPRTase activity, are indicated between 
the fifteenth and eighteenth weeks, however 
insufficient figures are available for statistical 
significance. 
Rat erythrocytes had a very low HGPRTase 
activity of 1.5 nmole/h /mg protein. 
Fig. 21 shows the body weight growth curve for 
P.V.G. rats, along with the growth curve for testis 
weight, each point being a mean derived from about 
10 rats 
3.5c. Discussion 
The developmental changes in rat tissue 
HGPRTase activity are complex, and do not follow a 
simple pattern of increase in activity with age. 
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In relation to the studies on developmental 
changes in human tissue HGPRTase activity presented 
in the previous section, it would appear that the 
rat may not be a satisfactory model. There are 
at least two important differences between human 
and rat tissues with respect to HGPRTase activity. 
Rat erythrocytes were found to have a very low 
HGPRTase activity, while Murray (1966) detected no 
activity. Human erythrocytes have relatively high 
HGPRTase activity. Also, rat liver contains very 
high HGPRTase activity with respect to other rat 
tissues and when compared to human liver. 
Further evidence of interspecies differences 
in the distribution and activities of the PRTases 
are presented by Krenitsky (1969) who showed that 
Rhesus monkey skeletal muscle had twice the APRTase 
activity of monkey liver. Human skeletal muscle 
has only a small fraction of the APRTase activity of 
liver (section 3.4; Rosenbloom et al., 1967b). In 
view of these and other possible differences in the 
role of the PRTases in different species, the use of 
animal models may not always be appropriate in the 
study of human developmental enzymology. 
Developmentally, newborn rats are comparable to 
five to ten day old human neonates (Davison and Dobbing 
104. 
1966), and the sharp rise in HGPRTase activity 
observed in several rat tissues during the first 
week of extrauterine life would correspond to the 
last weeks of foetal life in human babies. 
The tissues studied in this work would appear 
to be of two groups. The liver, cerebral cortex, 
and testis, show rapid increases in activity after 
birth, while the brain stem, basal nuclei, and kidney 
show smaller increases in activity one week after 
birth. 
A recent study on the development of HGPRTase 
activity in rat brain by Gutensohn and Guroff (1972) 
found HGPRTase activities in rat brain comparable 
to those detected in this study. These authors 
sampled rats daily during the first three weeks of 
life and as in this study detected a rapid rise in 
activity after birth. However, only one 
determination at seven weeks was subsequently made 
before the thirteenth week and these authors have 
concluded that rat brain HGPRTase activity plateaus 
after three weeks. It would appear that the 
fluctuations in brain HGPRTase activity have been 
overlooked due to inadequate sampling, although 
detailed examination of the data of Gutensohn and 
Guroff (1972) in fact suggest a slight fall in 
105. 
activity at twenty and twenty -one days. A 
final brain HGPRTase activity sample was carried 
out at twenty -six weeks, at which time the HGPRTase 
activity was at the 19 - 20 day level. The data 
presented in the present study show that in old 
age at sixty -five weeks HGPRTase activity is very 
low in all the tissues studied. 
The tissue distribution of ten week old rat 
PRTases has been studied by Murray (1966), however, 
direct comparison with the values obtained in this 
work is difficult due to this author's choice of 
25oc for the assay and also the present finding that 
the relative tissue HGPRTase activities are time 
dependent. Murray (1966) found high HGPRTase activity 
in brain and in bone marrow but detected no activity 
in the rat erythrocyte. Murray (1966) also noted 
a rapid rise in PRTase activity in liver occurring 
one day after partial hepatectomy, and concluded that 
the physiological significance of the PRTases in 
rapidly growing tissues was either in the importing 
of extracellular purines derived from other organs 
or the conservation of intracellular purines formed 
by nucleotide degradation. 
Murray (1967) also detected increases in PRTase 
activity in the developing mouse liver and reported 
106. 
changes in the kinetic constants for PRPP of 
both HG and APRTase during development. 
There are no reported studies on HGPRTase 
activities on the testis in rats or any other 
species. 
This study shows that testicular HGPRTase 
activity is related to both morphology and function. 
The peaks of testicular HGPRTase activity at three 
and seven weeks (Fig. 19) correspond to infections 
in the testis growth curve at four and seven weeks 
(Fig. 21). The maximum testicular HGPRTase 
activity at fifteen weeks corresponds to the 
attainment of full reproductive capacity in this 
strain of rat. 
It is not at present possible to relate, in 
any relatively simple fashion, the changes in 
HGPRTase activity detected in the central nervous 
system to functional events. 
The fluctuations in HGPRTase catalytic activity 
may represent increased synthesis of enzyme protein, 
however, alternative hypotheses are possible.. 
These include the stabilisation of existing 
protein by increased substrate levels (see Schimke, 
1969) so that catalytic activity increases to meet 
the increased requirements. Alternatively, the 
107. 
kinetic constants of HGPRTase could be modified 
by an allosteric effector, possibly of endocrine 
origin, thus increasing catalytic rates. 
Unfortunately, the data available do not allow 
any conclusion to be made as to which of these 
mechanisms may be operating 
3.6 ATTEMPTS TO DETECT AND CHARACTERISE TISSUE SPECIFIC 
ISOENZYMES OF HUMAN HYPDXANTHINE:GUANINE PHOSPHO- 
RIBOSYLTRANSFERASE 
3.6a. Introduction 
The widely differing tissue activities of 
HGPRTase, and the developmental changes found to 
occur with respect to the enzyme's activity would 
suggest that the role of HGPRTase may vary between 
tissues. Accordingly, it would be reasonable to 
expect to find isoenzymes in different tissues with 
a range of kinetic properties. 
The properties of HGPRTase from various tissues 
at different stages of development were investigated, 
using the techniques of electrophoresis, thermal 
denaturation, and enzyme kinetics. 
Electrophoresis of HGPRTase and APRTase was 
carried out using starch gel and cellulose acetate 
support media as described in section 2.7a. The 
tissues studied by this method were foetal brain and 
liver, brain, testis, liver, and erythrocytes from 
108. 
children, and testis and erythrocytes from adults. 
Dialysed homogenates of tissues were treated 
with sodium dodecyl sulphate and with urea in an 
attempt to alter the electrophoretic pattern by 
dissociation of any subunit structure of the 
HGPRTase protein. 
Samples of erythrocyte lysates were heat 
treated at 80oC for five minutes, and both heat 
treated and untreated samples were used for electro- 
phoresis. 
The specificity of the detection method was 
confirmed from the identity of both the radiochemical 
product and some aspects of the enzymic mechanism; 
the methods used were those described in section 2.7c. 
Complementary to the electrophoretic studies, 
the thermal denaturation rate constants were 
determined for HGPRTase from various tissues at 
differing stages of development. The tissues 
studied were erythrocytes, brain, liver and testis 
from children and from adults, and adrenals, kidney 
and spleen from adults only. 
Thermal denaturation has been used successfully 
by Kelley et al. (1969) to demonstrate the existence 
of both heat labile and heat stable mutants of 
erythrocyte HGPRTase. The patients studied by Kelley 
109. 
et al. (1969) had a family history of gout and 
over -excretion of urinary uric acid. The 
studies showed that compared with a control 
population, these families had polymorphic forms 
of HGPRTase. 
The results presented in this section are the 
specific reaction rate constants for the thermal 
denaturation of the enzyme protein, measured by 
the loss of catalytic activity. The treatment used 
in this work enables the results to be presented 
numerically and treated statistically. This method 
is more precise than the visual comparison of the 
thermal denaturation rate curves. 
In spite of the difficulties in interpreting 
kinetic constants obtained from crude enzyme 
preparations, apparent Michealis constants (Km) and 
maximal velocities (Vmax) were determined for 
hypoxanthine in the HGPRTase system from erythrocytes, 
liver, cerebral cortex, thalamus, and testis. 
Altered kinetic constants have been detected 
for human erythrocyte HGPRTase of differing heat 
stabilities (Henderson et al., 1968). Murray (1967) 
has reported changes in kinetic constants for APRTase 
during developmental changes in APRTase activity in 
mouse liver. 
110. 
The kinetic constants presented were obtained 
from crude tissue homogenates by determining the 
initial velocity at a series of substrate 
concentrations. Thé values were obtained from 
an Olivetti Programma 101 programmed to calculate 
the constants according to the methods of both 
Lineweaver -Burk and of Hofstee -Eadie (Dixon and 
Webb, 1967) . 
3.6b. Results 
The electrophoretic pattern obtained for 
HGPRTase was similar in all tissues studied and at 
all the ages studied. 
The electrophoresis of the PRTases is shown in 
Fig. 22. The bars of the histograms represent the 
C.P.M. per centimetre of D.E.A.E. paper used as 
described in section 2.7b. 
Electrophoresis was carried out using both 
cellulose acetate and starch gel as a support 
medium, and identical results were obtained from 
both media. 
The electrophoretic separation obtained for 
HGPRTase and APRTase is presented (Fig. 22). Four 
bands of activity were detected for the PRTases 
in every tissue examined. 










5 10 15 
DISTANCE FROM ORIGIN IN cm 
ELECTROPHORESIS OF PRTases 
SIMILAR SEPARATIONS WERE OBTAINED USING STARCH GEL OR CELLULOSE ACETATE 
Fig. 22 
located, but by allowing the current to flow 
for a shorter period of time the fourth band 
was detected on the thirteenth or fourteenth 
centimetre from the origin. 
In the case of HGPRTase, the peak nearest 
the origin (cathode) was always the major band and 
located at the third and fourth centimetre. The 
second, third and fourth bands, in order of 
increasing mobility were located at the eighth, 
tenth and thirteenth centimetres from the origin 
respectively. Minor variations of one centimetre 
were observed to occur between the positions of 
bands when electrophoresis was carried out in triplicate. 
A more regular distribution of activity among 
the bands of APRTase was noted Fig. 22. The 
slower migrating band of activity located nearest 
to the origin represented more catalytic activity 
than the minor bands, however, the difference between 
major and minor bands was not so marked as that 
found with HGPRTase. The bands of APRTase activity 
were located in the fourth, seventh, ninth and 
twelfth centimetres from the origin. The distance 
between the faster migrating minor bands was the 
same for both HG and APRTase. In order of mobilities, 
one centimetre separated the second and third bands, 
112. 
and two centimetres separated the third and 
fourth bands. 
When this work was carried out, only one 
band of activity had been reported for electro- 
phoresis of both HG and APRTase. It was 
therefore essential to check that the bands of 
activity were due to PRTase activity, and that the 
radiochemical products were in fact 5' -mono- 
nucleotides. Following electrophoresis, the 
bands of activity were located using a medium 
containing E .D .T .A., a non -specific inhibitor of 
the PRTases, and also a medium containing 
6- mercaptopurine, a specific inhibitor of HGPRTase. 
When compared to a control, these showed 
significantly reduced activity (Figs. 23 and 24) . 
Following localisation of the bands of PRTase 
activity, the D.E.A.E. strip was halved 
longitudinally, and one half treated with 
5'- nucleotidase EC 3.1.3.5, and4 enzyme specific 
for the hydrolysis of the 5' phosphate group from 
mononucleotides. Compared to the control, this 
showed (Fig. 24) a significant reduction in activity. 
These results would indicate that the enzymes 
involved are in fact the PRTases, and that the 
radiochemical products being measured are 
CONTROL 
40 mM EDTA 
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5 10 15 
DISTANCE FROM ORIGIN IN cm 
EFFECTS OF 6- MERCAPTOPURINE AND OF 5'- NUCLEOTIDASE 




Thermal denaturation studies Thermal 
denaturation studies on HGPRTase carried out 
at 55 °C and 64 °C gave results as shown in Fig. 25. 
After initial loss of catalytic activity, 
a subsequent increase in activity-was detected. 
This phenomenon of thermal reactivation is not 
fully understood. 
The type of curve obtained for thermal 
denaturation of HGPRTase at 80 0C is presented in 
Fig. 26. 
This curve (Fig. 26) can be transformed into 
a linear plot by the use of logarithims, for the 
theoretical treatment (section 2.8), and the 
results obtained are shown in Fig. 27. 
The thermal denaturation rate constants (k) 
derived as described in section 2.8 for human 
tissue HGPRTase, are presented in Table XXVII. 
The kidney, spleen, adrenals, and cerebral cortex 
were from adults, while the erythrocyte samples 
were from three children and two adults, the 
liver from four children and one adult, and the 
testis from three children and one adult. When 
tissues from both children and adults were studied, 
no marked difference was detected in the values obtained. 
TIME 
4 6 
IN MINUTES AT 64 °C 
10 
THERMAL DENATURATION AND SUBSEQUENT 
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TIME IN MINUTES AT 80 °C 
DECREASE IN HGPRTase ACTIVITY WITH TIME 
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THERMAL DENATURATION RATE CONSTANTS FOR 
HYPDXANTHINE GUANINE PHOSPHORIBOSYL- 




Rate Constant (Min -1) 
Mean ± Standard 
Deviation 
Erythrocytes 5 0.II46± 0.006 
Liver 5 0.1122± 0.035 
Testis 4 0.05I5± 0.0007 
Cerebral cortex 2 0.0855± 0.009 
Basal nucleus 1 0.064 
Kidney 2 0.II0 
Spleen 1 0.III 
Adrenal 1 0.052 
10 15 20 
AMOUNT OF ENZYME (pl) 
25 









































































































































































































































































































































































































































































































































































































Enzyme kinetics Using tissue homogenates 
from cerebral cortex, the mass of substrate 
hypoxanthine transformed was not a linear 
function of the volume of enzyme used (Fig. 28). 
Similar results have been obtained by Murray (1971) 
using brain homogenates. The other tissues 
studied produced linear plots of substrate 
transformed versus volume of enzyme added. 
The means S.D. of the apparent Kms and Vmax 
as determined by the methods of Lineweaver -Burk 
and Hofstee -Eadie are presented for the tissues 
studied in Table XXVIII. All estimates were 
prepared in duplicate, thus the number of tissue 
samples used was half the number of determinations. 
All the tissues were obtained from children with 
the exception of one adult testis sample which did 
not show a markedly different result. 
3.6c Discussion 
Electrophoretic studies The electrophoretic 
detection methods used in this study represent a 
considerable improvement on methods previously used. 
Prior studies on the electrophoretic properties of 
HGPRTase using starch gel (Kelley et al., 1969; 
Kaloustain et al., 1969) detected only one band of 
HGPRTase activity. In this work, four zones of 
115. 
HGPRTase activity were detected in all tissues 
studied. Similarly, four zones of APRTase 
activity were located. 
The identity of the radioactive products 
were shown to be nucleotide monophosphates by 
hydrolysis by 5'- nucleotidase, and the enzymes 
forming this product shown to be HGPRTases by 
their inhibition by E.D.T.A. and 6- mercaptopurine. 
The electrophoretic detection method was 
found to be semi -quantitative; doubling of the 
sample loaded onto the electrophoresis support 
medium produced an approximate doubling of peak 
height. 
Recently, Bakay and Nyhan (1971) using a high 
resolution polyacrylamide gel slicing technique, 
have also demonstrated the existence of four bands 
of activity for normal HGPRTase, although only one 
band of APRTase activity was reported. 
HGPRTase has been purified to homogeneity 
by Arnold and Kelley (1971), and while only one 
band of activity was eluted after chromatography 
on D.E.A.E. cellulose, three bands of activity were 
detected after isoelectric focusing. 
The three bands obtained on isoelectric 
focusing migrated at different rates in polyacrylamide 
116. 
disc gel electrophoresis, however, a mixture 
of the three bands from the isoelectric focusing 
column migrated in polyacrylamide gel electro- 
phoresis as a single band to a position identical 
with the isoenzyme band of intermediate mobility. 
All three of the isoenzyme bands were 
immunologically identical and all had molecular 
weights of 34,000 
± 
4,000. No sialic acid 
residues were detected on any of the three isoenzymes. 
In the present study, treatment of the tissue 
homogenates with 1 M urea or 10% sodium dodecyl 
sulphate, or heat treatment at 80°C had no 
detectable effects on the electrophoretic properties 
of HGPRTase. 
It should be noted that although no alteration 
of the major peak was detected after treatment with 
10% S .D .S ., this compound was not included in the 
gel buffer and the unaltered electrophoretic 
pattern could be due to rapid reassociation. 
As a single mutational event results in the 
complete deficiency of HGPRTase, the existence of 
multiple forms of HGPRTase from more than one gene 
is unlikely. 
The isoenzymes detected in this and other 
studies could arise from either post -transcriptional 
117. 
alterations to the enzyme protein, or 
alternatively, be due to dissociated subunits 
of a polymeric protein. 
In view of the immunological similarities 
in the subunits, the identical molecular weights, 
the reassociations detected (Arnold and Kelley, 
1971) and the fact that the slowest migrating band 
found in this study was always the major band, the 
evidence available would suggest a polymeric 
protein, in equilibrium with catalytically 
competent subunits. 
No differences in electrophoretic properties 
were detected in HGPRTases from different tissues, 
but the presence of a complex polymeric protein 
may suggest different associative and regulatory 
properties in individual tissues. 
Thermal denaturation studies Thermal 
denaturation studies of enzymes can detect small 
differences in protein structure. London, Wigler 
and Hudson (1954) studying prostatic acid phosphatase 
showed that the rate of protein denaturation, as 
measured by loss of catalytic activity, was a 
sensitive function of buffer anion, buffer pH, and 
temperature. Changes of 0.1 pH unit or of 1 °C 
were 
reflected in changes in the denaturation rate. 
118. 
Thermal denaturation of HGPRTase carried 
out at 50 and 64 °C showed initial loss of 
activity and subsequent thermal reactivation. 
This phenomenon has been reported (Jack, 1971) 
but is not fully understood. 
The rate constants derived and presented in 
Table XXVII were highly reproducible in 
erythrocytes and testis, but the results from 
liver, cerebral cortex and kidney were more variable. 
The denaturation rate constant for testicular 
HGPRTase was significantly different from the mean 
of all other tissues by the Student t -test 
0.02<p<0.05. However, the denaturation rate 
constant for the adrenal HGPRTase was similar to 
that for the testis. It is possible that in these 
two functionally similar tissues with high hexose 
monophosphate shunt activities and possible high 
ribose -5- phosphate generating capacity (Mayes, 1967), 
high PRPP levels may be present stabilising the 
enzyme (Greene et al., 1970). This does not exclude 
the possibility that an altered HGPRTase may be 
present. 
APRTase of differing heat stabilities has 
been 
reported in sections of rat jejunal villi from 
the 
tip to crypt (Earl Balis, Brown and Cappucino, 
1971) 
119. 
and two enzyme forms are suggested, a heat 
labile and a heat stable form, and that the 
heat labile form was short -lived in vivo. 
Kinetic studies Apparent Michealis 
constants for erythrocyte HGPRTase with 
hypoxanthine as a substrate have been reported 
by Henderson (1968). Similar values have been 
obtained in this study. The apparent Kms for 
erythrocyte and testis HGPRTase were reproducible, 
but a wider range of results was obtained when 
determining these constants for liver, cerebral 
cortex, and thalamus HGPRTase (Table XXVIII). 
Due to the possible presence of enzyme systems 
other than HGPRTase metabolising either substrate 
or product, both at very low concentrations, kinetic 
constants must be interpreted with caution. 
However, the apparent Km values calculated by the 
method of Hofstee -Eadie yielded more reproducible 
results than the method of Lineweaver -Burk, and, 
under the condition of assay showed a reasonable 
agreement between the values obtained from the 
different tissues. 
The different denaturation rate constants for 
the testis would suggest the possibility of a tissue 
specific form of HGPRTase localised in the testis, 
120. 
although the possibility of substrate 
stabilisation has already been indicated. 
As the electrophoretic and other evidence suggests 
that HGPRTase is a polymeric protein, the 
possibility of tissue specific subunit interactions 
should be considered, as subunit interactions 
have been reported by Bakay et al. (1972) to 
alter the apparent activity of HGPRTase. The 
phenomenon of protein -protein interactions has 
been recognised as a major factor in the 
regulation of enzyme activity in vivo (Frieden, 
1971) . 
3.7 STUDIES ON THE TRANSPORT OF PURINES BY 
ERYTHROCYTES 
3.7a. Introduction 
The role of HGPRTase in the purine 
metabolism of the whole animal and the consequences 
of its deficiency in the pathology of the Lesch- 
Nyhan syndrome are less well understood than is 
its role in the cell. 
It has been felt for some time that there 
might be two types of tissue, one exporting purines, 
the other importing purines. In 1956 Smellie 
et al. reported that [14C] formate was incorporated 
into nucleic acid bases in rabbit bone marrow 
and 
121. 
tumour cells, and they suggested that some 
tissues might be dependent on exogenously 
supplied purines. 
The work of Lajtha and Vane (1958) showed 
that the bone marrow depended on the liver for 
its purine supply and many groups of workers 
have since suggested that the liver may act as 
a purine exporting tissue. 
Liver contains high activities of PRPP 
amidotransferase - the rate limiting enzyme in 
de novo purine biosynthesis (Caskey, Ashton and 
Wyngaarden, 1964) - and has been shown by Howard, 
Kerson and Appel (1970) to have four to five 
times the capacity of brain tissue for de novo 
purine biosynthesis. 
Transport of purines between tissues would 
appear to be a function of the erythrocytes 
(Henderson and Le Page, 1959) and, as these cells 
cannot synthesise purines de novo (Lowry and 
Williams, 1960), any turnover of purine nucleotides 
in the erythrocyte must result from the entry and 
release of purines from these cells. Murray (1971) 
has calculated that for a 70 kg man there is an 
erythrocyte nucleotide turnover of 6 mg of purine 
base per kg body weight every twenty -four hours. 
122. 
Pritchard, Chavez -Peon and Berlin (1971) 
reported that rat liver prelabelled with 
adenine- [8 -14C] loses label to the non -hepatic 
tissues, but that erythrocytes maintain labelled 
hypoxanthine and guanine for six days despite 
the short turnover time of nine hours for the 
erythrocyte nucleotide pool. 
Hypoxanthine has been shown to be the major 
purine released from human red cells (Jorgensen 
and Poulsen, 1955) and Hershko et al. (1967) have 
reported that hypoxanthine is the major purine 
released from rabbit red cells irrespective of the 
purine incorporated. 
As the uptake of hypoxanthine by erythrocytes 
is dependent on a catalytically competent HGPRTase 
(Sperling et al., 1971), this work was carried out 
to determine if the uptake of hypoxanthine by 
tissues from rabbit erythrocytes in vivo was 
related to the tissue HGPRTase activity. 
Results are presented showing the uptake of 
radioactive hypoxanthine by human erythrocytes, 
incubated as described in section 2.12a. The PRTase 
activities found in rabbit tissues are presented 
along with the uptake of labelled purine from the 
prelabelled erythrocytes by these tissues. 
123. 
3.7b. Results 
The uptake of hypoxanthine- [8 -14C] by 
human erythrocytes is shown in Fig. 29 and 
shows a linear relationship with time after 
thirty minutes. The cause of the lag phase 
in the first thirty minutes is unknown. 
Prior to studying the transportation of 
purines by rabbit erythrocytes, the tissue PRTase 
activities from the strain of rabbits was 
determined. These activities are presented in 
Table XXIX and the figures represent the means 
of duplicate determinations on tissues from two 
adult rabbits. 
Highest HGPRTase activity was found in the 
testis, and high activity was also found in the 
brain. Lower activity was detected in the liver 
and erythrocyte, and very little activity was 
detected in the kidney and muscle. 
APRTase activity was high in kidney and in 
liver, low activities being detected in other 
tissues. 
The tissue uptake of radioactive purines from 
erythrocytes in vivo is shown in Table XXX. The 
fractions examined for radioactivity were the 








TIME IN MINUTES 30 60 90 120 
UPTAKE OF HYPDXANTHINE -8 -C14 BY HUMAN ERYTHROCYTES 
Fig. 29 
TISSUE HGPRTase 
nmole /h /mg /protein 
APRTase 
nmole /h /mg protein 
Brain 230 57 
Kidney 15 133 
Liver 86 92 
Muscle 14 23 
Testis 290 61 
Erythrocyte 125 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































RNA fraction, and the DNA fraction. These 
were isolated as described in section 2.12 from 
brain, kidney, liver, muscle and testis. 
The figures represent the disintegrations 
per minute per gram wet weight of tissue in 
column one, and this figure as a fraction of the 
total dose of radioactivity administered x 106 
in column two. 
The figures show that significant uptake of 
purines by tissues from erythrocytes has taken 
place. The perchloric acid soluble nucleotide 
fraction contained the majority of the radioactivity, 
lower levels being detected in the RNA and DNA 
fractions. 
An approximate measure of the requirements 
for nucleotides for nucleic acid synthesis in these 
tissues is given by the ratio of the radioactivity 
in the perchloric acid soluble fraction to the 
total radioactivity in the RNA and DNA fractions. 
This is presented in Table XXXI. 
These figures would suggest that brain and 
muscle have a high requirement for nucleotides for 
nucleic acid synthesis. 
The means ± S.E.M. for experiments 2, 3, and 4 
of uptake of 14C purine are presented in Table III. 
TABLE XXXI 
THE RATIO OF THE P.C.A. SOLUBLE RADIOACTIVITY 
TO THE RADIOACTIVITY IN THE RNA AND DNA 
FRACTIONS FROM EXPERIMENTS 2, 3 and 4 
Tissue 
P.C.A.- soluble 
D.P.M. /g Tissue 
(RNA + DNA) 
D.P.M. /g Tissue 
P.C.A. 
(RNA + DNA) 
Brain 643 234 2.7 
Kidney 983 195 5.0 
Liver 1425 116 12.3 
Muscle 637 152 4.2 
Testis 1201 67 18.0 
TISSUE UPTAKE OF RADIOACTIVE PURINES FROM RABBIT ERYTHROCYTES in vivo 
Erythrocytes were labelled in vitro, administered to the donor rabbit, 
and uptake into tissues measured after 45 hours. Results are expressed 
as Means : S.E.M. from 3 experiments and are calculated as 
radioactivity per gram wet weight of tissue 
x 106 
radioactivity administered to the whole animal 
TISSUE (Fraction of 
tissue, calculated 
Uptake of 14C purine 
of dose per gram wet weight 
as 
PCA -soluble RNA DNA 
Brain 643 ± 142 207 ± 149 27 x 6 
Kidney 983 y 59 156 ± 54 39 ± 10 
Liver 1425 z 190 89 s 32 27 ± 8 
Skeletal Muscle 637 ± 141 126 x 60 26 . 12 















































































































































































































































































































































































































































































































































































































































































































































































A similar pattern was obtained when the 
incorporation was related to the RNA and DNA 
extracted. 
The results are also presented graphically 
in Fig. 30 where the logarithm of the fraction 
of the radioactive dose is shown for the DNA, RNA, 
and PCA soluble fractions in brain and in liver. 
Similar results were obtained in kidney, muscle, 
and testis. 
The data on the animals used and the gross 
distribution of the radioactivity in the animals 
for experiments 1 to 4 are presented in Table VIII. 
The first experiment was carried out with 
a short in vivo incubation, and no allopurinol was 
given. In experiments 2, 3 and 4, the duration 
of the in vivo incubation was 45 h, and increasing 
doses of allopurinol were given. About half of 
the radioactivity administered in the erythrocytes 
was incorporated into the tissues studied, the bulk 
of the remainder being in the urine despite the 
administration of allopurinol. A large 
proportion of radioactivity was found in the 
erythrocytes in experiment 1 with the short 
incubation period, but on increasing the time of 
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the erythrocyte fell to nearly zero. 
The radioactivity unaccounted for was 
probably distributed in the tissues not 
studied. 
The urine was examined to determine the 
source of the radioactivity using a cellulose 
thin -layer system with a solvent of 1 M ammonium 
acetate pH 7.0. No radioactivity was detected 
in spots corresponding to hypoxanthine, xanthine 
or urate. The urinary radioactive moiety had 
an Rf value of 0.81 in this system (Table XXXIV) 
and was probably allantoin or allantoic acid. 
The effects of increasing dosage of 
allopurinol or incorporation of hypoxanthine-[8-14C] 
into RNA is shown in Fig. 31. The logarithm of 
the fraction of the radioactive dose incorporated 
into tissue RNA is shown for experiments 1, 2, 3, 
and 4. 
The histogram shows an increased percentage 
incorporation as the dose of allopurinol was 
increased. 
The relationship between tissue HGPRTase 
activity and fraction of radioactive dose 
incorporated per unit blood flow is presented in 
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Urinary radioactivity 0.81 
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incorporated increases with HGPRTase activity 
in kidney, brain, and testis, but liver and 
muscle showed high incorporation of radioactive 
dose with a low tissue HGPRTase activity. 
It was felt justifiable to examine the 
effect of correcting the incorporation values 
for blood flow rates, as the mass transfer of 
compounds by the circulatory system will be 
dependent on blood perfusion rates. It must be 
emphasised however that Fig. 32 is speculative. 
The blood flow rates were derived from the 
limited number in the literature (see Hamilton, 
1963) but accurate data were available for testis 
(see Setchell, 1970) . 
It is possible that in this study the 
fraction of the radioactive dose incorporated 
into RNA has been underestimated due to the 
hydrolysis of RNA by RNase during the period of 
about 1 h between death and extraction of the RNA 
fraction. 
The rather high incorporation of label into 
brain DNA could be due to contamination by RNA 
(see section 2) but active mitotic activity has 
been reported in the ependyma (Watson, 1965). 
3.7c. Discussion 
The results of the preliminary experiments 
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showed that hypoxanthine was rapidly 
incorporated into the human erythrocyte. 
The transport of hypoxanthine across the 
erythrocyte membrane has been shown to be 
an active process, and linked to urate transport 
(Larsen and Overgaard- Hansen, 1962; Christensen 
and Jones, 1961) . The reason for the initial 
lag phase observed is not understood. 
About 10% of the label in the incubation 
medium moved into the rabbit erythrocyte during 
incubation. 
The PRTase activities in adult rabbit tissues 
were found to be lower than those in man but the 
ranking of the tissue activities was similar to 
that found in human tissues with the exception of 
the high APRTase activity found in rabbit kidney. 
Whereas human erythrocytes cannot convert IMP 
into AMP (Lowry, Williams and London, 1962), in 
the rabbit erythrocyte IMP can be converted into 
AMP or GMP (Lowry, Williams and London, 1961). 
This interspecies difference between the rabbit 
and human erythrocyte could possibly affect the 
metabolism and release hypoxanthine, but the studies 
by Herschko et al. (1967) on rabbit erythrocytes 
suggest that the main purine released by the rabbit 
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erythrocyte is hypoxanthine irrespective of 
the purine incorporated. 
Radioactive hypoxanthine from rabbit 
erythrocytes was incorporated into tissue 
nucleic acids in all the tissues studied, and 
when corrections were made for blood flow rates, 
the incorporation into kidney, brain, and testis 
was related to the tissue HGPRTase activity. 
As was expected, a high incorporation 
into the liver P.C.A. soluble fraction was 
detected. This was probably a reflection of 
the role of the liver in the catabolism of the 
purine ring system to urate and allantoin. 
An unexpected finding was the high incorporation 
of label into skeletal muscle, when corrected 
for blood flow rates. A large increase in the 
urinary excretion of hypoxanthine after muscular 
work has been reported by Nasrallah and Al- Khalidi 
(1964) and this tissue may depend on exogenous 
purines to compensate for this loss. No 
information was found in the literature regarding 
muscle tissue capacity for de novo purine 
biosynthesis. 
Although the nature of the purine released 
by the liver is uncertain, some deductions can be 
made about its 
unable to pass 
r 
to the cha fges 
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nature. Nucleotides 
through cell membranes 




1958), and the inhibition of nucleoside 
transport across the erythrocyte membrane by 
p- nitrobenzylthioguanine has no effect on the 
turnover rates of the erythrocyte nucleotide 
pool (Brown and Paterson, 1971). It would 
appear likely, therefore, that the moiety 
released by the liver is a free purine base. 
As the erythrocytes do not contain xanthine oxidase 
EC 1.2.3.2 (Al- Khadimi and Chaglassian, 1965) but 
posessgu anine aminohydrolase EC 3.5.4.3 activity 
(Jorgensen, 1956) the most likely base would 
appear to be hypoxanthine. The recycling of 
hypoxanthine has been reported by Bradford et al. 
(1968) who studied xanthinuric patients, and 
found that the bulk of the daily pool of 276 mg 
of xanthine was excreted, while only 6% of the 
960 mg hypoxanthine pool was excreted. 
This and other data (see section 3.4) would 
suggest that hypoxanthine is the principal substrate 
for HGPRTase, and that this base is extensively 





A balanced supply of purine and pyrimidine 
nucleotides for co- enzymes and nucleic acid 
synthesis is a prerequisite for growth. There 
is considerable evidence to suggest that the 
purine phosphoribosyltransferases are important 
pathways for the synthesis of purine ribo- 
nucleotides in rapidly growing tissues. High 
PRTase activities have been detected in 
regenerating liver after partial hepatectomy 
(Murray, 1966) in germinating grain (Price and 
Murray, 1969) and in tumour cells (Smith et al., 
1971). Human spermatozoa do not contain HGPRTase 
activity (section 3.4), but mouse ova contain low 
levels of both HG and APRTase activities which, 
after fertilisation, increase by a factor of about 
twenty at the blastocyst stage (Epstein, 1970). Low 
activities of the PRTases were detected in human 
foetuses at eight weeks (section 3.4). 
The biosynthesis of purine ribonucleotides 
by tissues can proceed via the de novo pathway or 
by the 'salvage' pathways. Although little 
information is available on the capacity of human 
tissues for de novo biosynthesis, it is suggested 
that a balance between the two pathways exists, 
whereby tissues whose nucleotide requirements are 
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not met by de novo synthesis use HGPRTase to 
maintain these needs. Testis and central 
nervous tissues are probably in this category, 
and possibly also bone marrow as children with 
the Lesch -Nyhan syndrome often present a 
megaloblastic anaemia. The intracellular salvage 
of purines is a result of the degradation products 
of nucleic acid breakdown being partially in the 
form of 3'- nucleotides, which require to be 
degraded to the free base level before being 
reformed into 5'- nucleotides (section 3.4). 
Another probable role of HGPRTase is in the 
salvage of extracellular purines, principally 
hypoxanthine, transported by the peripheral blood. 
That this process can occur has been demonstrated 
(section 3.7; Pritchard et al., 1970). The liver 
is the most probable source of purines for this 
transport process. The finding of HGPRTase 
localised in walls of blood vessels (section 3.4) 
may be of significance in this process. A similar 
role for APRTase has been demonstrated in bacteria, 
where adenine uptake was shown to be correlated 
with APRTase activity, and a large proportion of 
this enzyme was associated with the cell membrane 
(Hochstadt -Ozer and Stadtman, 1971) . 
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The role of human erythrocytes in purine 
transport has been emphasised by calculations 
made by Murray (1971). As human erythrocytes 
cannot synthesise purines de novo (Lowry and 
Williams, 1960) turnover of purines in these 
cells must be a result of the entry and release 
of purines. Murray (1971) calculated that for 
a 70 kg man, a total daily turnover of 450 mg of 
purine base occurred. 
Children with the Lesch -Nyhan syndrome, 
deficient in HGPRTase, synthesise purine 
nucleotides de novo greatly in excess of normal. 
It is suggested that this increase in de novo 
synthesis is a compensatory result of the deficiency 
of intracellular purine nucleotides. Free 
hypoxanthine derived from extracellular sources 
or from adenosine breakdown will be recycled to 
form nucleotides; in the absence of HGPRTase 
these will be oxidised to urate and excreted. 
This will pull the equilibrium of this system 
towards purine catabolism, and de novo purine 
biosynthesis will increase in an attempt to meet 
the requirements of the tissue. This conclusion 
is reinforced by the failure to grow of cultured 
skin fibroblasts from Lesch -Nyhan children without 
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the addition of supplementary adenine to the 
culture medium (Felix and De Mars, 1969). 
The relationship between behaviour, drive, 
aggression and intelligence with plasma uric 
acid levels (Kasl, Brooks and Rodgers, 1970) is 
of great interest when it is considered that 
Lesch -Nyhan children exhibit pathologically 
aggressive and compulsive drive behaviour. There 
may be a functional relationship between serum 
urate and the end products of cerebral purine 
metabolism. 
Pyrimidine nucleotide biosynthesis in 
tissues will be related to purine nucleotide 
biosynthesis, and recent work by Tatibana and 
Shigesada (1972) has shown that PRPP regulates 
the activity of carbamyl phosphate synthetase. 
PRPP is a very important rate limiting substrate 
in purine biosynthesis (see section 1.7) and this 
would suggest a mechanism for the control of both 
purine and pyrimidine biosynthesis pathways. In 
addition, XMP has been shown to regulate the 
activity of orotidine monophosphate decarboxylase 
(Kelley and Beardmore, 1971), an enzyme in the 
pyrimidine biosynthetic pathway. 
It is of interest that at present a controversy 
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exists in the literature regarding the 
capacity of the brain for de novo pyrimidine 
nucleotide biosynthesis. Some workers, for 
example, Hogans, Guroff and Udenfriend (1971) 
and Santos et al. (1968) suggest that the brain 
relies on preformed pyrimidines and forms 
pyrimidine nucleotides by the salvage reactions 
of uridine and cytidine kinase, whereas Bourget 
and Tremblay (1972) claim that brain is not 
dependent on the pyrimidine salvage pathways and 
can meet its needs by de novo synthesis. 
The pathology of the Lesch -Nyhan syndrome 
would, however, strongly suggest that at least in 
man the central nervous tissues are dependent on 
preformed purines for nucleotide supplies. 
Although no testicular pathology has been reported 
in Lesch -Nyhan children, the present work suggests 
HGPRTase is important in spermatogenesis. 
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The Development of Hypoxanthine /Guanine 
Phosphoribosyltransferase Activity in Man 
By A. ADAMS, J. M. ANDERSON, A. D. NIcoL and 
R. A. HARKNESS. (Departments of Paediatric 
Biochemistry and Pathology, Royal Hospital for 
Sick Children, and Department of Clinical Chemistry, 
University of Edinburgh EH9 1LJ, U.K.) 
Hypoxanthine /guanine phosphoribosyltransfer- 
ase (EC 2.4.2.8) is important to man. Its absence 
is associated with the childhood syndrome of 
mental deficiency, self- mutilating behaviour and 
hyperuricaemia (Nyhan, 1968). The enzyme 
catalyses the conversion of 5- phosphoribosyl 1- 
pyrophosphate and hypoxanthine or guanine into 
the corresponding 5'- mononucleotides. 
The measurement of hypoxanthine /guanine 
phosphoribosyltransferase activity in tissues other 
than erythrocytes is complicated by destruction of 
the product by 5'- nucleotidase (EC 3.1.3.5). How- 
ever, 5'- nucleotidase can be inhibited by TTP 
(Murray & Friedrichs, 1969). Assays based on the 
method of Cartier & Hamet (1968) were performed 
on the 25000g supernatant from homogenates. 
When the hydrolysis of GMP by brain homogenates 
was decreased to 15% of control values by 1.5mM- 
TTP there was a fourfold increase in measured 
hypoxanthine /guanine phosphoribosyltransferase 
activity. Other tissues showed less marked changes, 
and activity in erythrocytes was unaffected. A 
survey in foetal, childhood and adult tissues showed 
that activity was present in all the tissues examined ; 
in most, including liver and kidney, little change 
occurred with growth and development. In con- 
trast, activity in regions of brain rose during the 
postnatal period to reach values that, in the adult 
were markedly higher than those in other tissues. 
Activity in the testis was also somewhat higher 
than those in other organs. 
Hypoxanthine /guanine phosphoribosyltransfer - 
ase activity can be separated into at least two 
components by electrophoresis on cellulose acetate 
or starch gel, there being no major alteration in the 
pattern from brain during development. Reaction 
products from both components were destroyed by 
5'- nucleotidase, and the reaction was inhibited 
partially by 0.7 mM -6- mercaptopurine and totally 
by 40mM -EDTA. No marked alteration in electro- 
phoretic pattern was observed after treatment with 
5 mM- sodium dodecyl sulphate. Electrophoretic 
separation of hypoxanthine /guanine phospho- 
ribosyltransferase components on polyacrylamide 
gel has also been reported by Bakay & Nyhan 
(1971). 
No differences in thermal stability were detected 
in different tissues. 
The distribution and activity of hypoxanthine/ 
guanine phosphoribosyltransferase seem consistent 
with its postulated `salvage' role and possibly with 
its involvement in the use of exogenous purines 
for cellular nucleotide biosynthesis (see Raivio & 
Seegmiller, 1970). 
A. A. is grateful to the University of Edinburgh for a 
Research Scholarship. 
Bakay, B. & Nyhan, W. L. (1971). Biochem. Genet. 5, 81. 
Cartier, P. & Hamet, M. (1968). Clinica chien. Acta, 20, 
205. 
Murray, A. W. & Friedrichs, B. (1969). Biochem. J. 111, 
83. 
Nyhan, W. L. (1968). Fedn Proc. Fedn Am. Socs exp. Biel. 
27, 1027. 
Raivio, K. O. & Seegmiller, J. E. (1970). Curr. Topics 
cell. Regulat. 2, 201. 
PRINTED IN GREAT BRITAIN BY WILLIAM CLOWES AND SONS LIMITED, LONDON, COLCHESTER AND BECCLES 
138 BIOCHEMICAL SOCIETY TRANSACTIONS 
more natural development of the cultivated cells, the use of brain extract may be of 
importance in establishing preparations of brain- cortex cells that are suitable for 
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Purine Uptake from Erythrocytes by Rabbit Tissues in vivo 
A. ADAMS and R. A. HARKNESS 
Departments of Paediatric Biochemistry and Clinical Chemistry, 
University of Edinburgh, Edinburgh EH9 1LJ, U.K. 
Liver can synthesize purines de novo about four times as rapidly as can brain (Howard 
et al., 1970) and has been shown to supply preformed purines for nucleic acid synthesis 
in bone marrow (Lajtha & Vane, 1958). In tissues other than liver, nucleotide bio- 
synthesis from preformed purines catalysed by the purine phosphoribosyltransferases 
(the salvage pathways) is important (see Murray et al., 1970). 
Transport of purines between tissues appears to be a function of the erythrocytes (see, 
e.g., Henderson & Lepage, 1959). The uptake of purines by erythrocytes is dependent 
on hypoxanthine /guanine phosphoribosyltransferase activity (EC 2.4.2.8) (Sperling 
et al., I 971). Since the major purine released from the erythrocyte is hypoxanthine (see, 
e.g., Hershko et al., 1967), tissue uptake might be related to its hypoxanthine /guanine 
phosphoribosyltransferase activity. Therefore the uptake of radioactive purines from 
rabbit erythrocytes in vivo by tissues with widely differing activities of this enzyme was 
investigated. 
The hypoxanthine /guanine phosphoribosyltransferase activities in rabbit testis, brain, 
liver, kidney, muscle and erythrocytes were 290, 230, 86,15,14 and 125 nmol /h per mg of 
protein respectively. Adenine phosphoribosyltransferase (EC 2.4.2.7) activities for the 
same tissues, with the exception of erythrocytes, were 61, 57, 92, 133 and 23 nmol/h per 
mg of protein respectively. Similar results have been obtained in the rat and in man 
(Adams et al., 1971). 
Radioactive hypoxanthine was incorporated into rabbit erythrocytes by the following 
method. About 10m1 of heparinized rabbit blood was incubated with 50 p.Ci of 
[8- 14C]hypoxanthine (specific radioactivity 59µCi /µmol) by the method of Mager et al. 
(1967); it was confirmed that 6 -15 % of this radioactivity was incorporated into the 
washed erythrocytes. These were injected into the donor rabbit, which was killed 45h 
later. The `nucleotide' fraction was extracted into 0.2M- HC1O4; RNA and DNA 
fractions were obtained by the methods of Birnstiel et al. (1972) and of Marmur (1961) 
respectively from testis, brain, liver, kidney and leg muscle. 14C in these extracts was 
measured by liquid- scintillation counting, and the amounts of RNA and DNA by u.v. 
spectrophotometry. The incorporation of the administered dose into the tissues, 
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Table 1. Tissue uptake of radioactive purines from rabbit erythrocytes in vivo 
Erythrocytes were labelled in vitro and administered to the donor rabbit, and uptake 
into tissues was measured after 45 h. Results are expressed as means±s.E.M. for three 
experiments and are calculated as: 
Radioactivity /g wet wt. of tissue 
x 106 
Radioactivity administered to the whole animal 
Uptake of [14C]purine 
(fraction of dose /g wet wt. of tissue) 
Tissue 1-IC104- soluble RNA DNA 
Brain 643 ± 142 207 ± 149 27 ± 6 
Kidney 983 ± 59 156 ± 54 39 ± 10 
Liver 1425 ± 190 89 ± 32 27 ± 8 
Skeletal muscle 637 ± 141 126 ± 60 26 ± 12 
Testis 1201 ± 305 51 ± 19 16 ± 3 
expressed as a fraction of the dose per g wet wt., is shown in Table 1: 57, 48 and 56 % of 
the administered radioactivity was incorporated into the tissues studied. Most of 
the remainder appeared in the urine despite the administration of allopurinol. An 
initial study of incorporation over only 4h showed 33 % uptake; therefcye the uptake 
from erythrocytes was rapid. 
The results show that there is no simple relationship between hypoxanthine /guanine 
phosphoribosyltransferase activity and the tissue uptake, although the testis does show 
a high uptake into the acid -soluble or `nucleotide' fraction. This is especially marked 
when some allowance is made for its relatively low blood flow per unit weight (see 
Setchell, 1970) when compared with liver and kidney. A relatively high uptake into 
brain RNA was also noted. The large amounts removed by muscle are difficult to explain 
except, possibly, by some exchange of muscle purines during the operation of the purine 
nucleotide cycle (see Lowenstein, 1972). Significant amounts of the dose appeared in the 
DNA fraction (Table 1), incorporation into RNA being greater and more variable than 
that into DNA, particularly in brain. 
The above evidence shows that tissue uptake of purines from circulating erythrocytes 
an take place; failure of this transport process may be important in the pathogenesis of 
the Lesch -Nyhan syndrome (see Kelley, 1972). It appears justifiable from the above re- 
sults to suggest that hypoxanthine /guanine phosphoribosyltransferase may also be 
important in the testis for the uptake of purines from erythrocytes. 
A. A. is indebted to the University of Edinburgh for a Research Scholarship. 
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